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C H A P T E R I 
T H E B A C K G R O U N D 
The gastrointestinal tract has a large functional reserve. This is 
particularly true of the small intestine, and early studies by Flint 
in 1912 (1), showed that dogs could withstand 50%-70% small intestinal 
resection, returning to normal health after an initial period of weight 
loss and malabsorption. No doubt, this reserve is in part due to the 
very high rate of epithelial proliferation in small bowel mucosa. 
Intestinal adaptation is the result of morphological and functional 
changes, and while these parameters can be accurately appreciated, 
the mechanisms by which these changes take place, are still under 
active investigation. 
This section summarises the changes, both structural and functional, 
in the adaptive process, and this is followed by a review of the 
background work done on the possible mechanism of adaptation. The 
normal anatomy of intestinal mucosa is however, considered first. 
Most of the work done to date in the field of intestinal adaptation, 
involves the small bowel, and this part of the gut will be discussed 
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CELL ORGANISATION AND RENEWAL IN INTESTINAL MUCOSA 
The epithelial system is divided into functional and prol
iferative 
compartments. The functional compartment is the epitheliu
m lining 
the villus, which is concerned with absorption, while the
 cells 
lining the crypts of Lieberkuhn, form the proliferative c
ompartment (2). 
Between these two areas, is the maturation compartment (F
ig 1.1), 
where cells are losing their proliferative capacities an
d acquiring 
the characteristics of mature, functional cells. The bou
ndaries of 
these compartments require kinetic measurements for their
 determination, 
as they are not structurally discrete. Two such measurem
ents, the 
labelling index, using tritiated thymidine (
3 HTdR) labelled cells, 
and mitotic index (metaphase arrest method), have been us
ed for this 
purpose (3,4). 
Cell division takes place in the base of the crypts of L
ieberkuhn (5). 
The complete cell cycle lasts for 24 hours in man (6) and
 10 to 17 hours 
in rodents (5), and consists of the M, Sand G phases. 
The epithelium 
is completely replaced in 2 to 3 days in rodents (7,8) an
d 3 to 6 days 
in man (6). After about two divisions in the crypts, th
e cells migrate 
up to the villus (9,10,) and become differentiated into m
ature columnar 
cells containing enzymes necessary for absorption (9,11).
 The cells 
are then extruded from the villus tip and under normal co
nditions, 
this cell loss from the villus tip equals cell birth, in 
the base of the 
crypt. Because of the decreased villus height in the di
stal compared 
with the proximal small bowel, cell migration is complete
d more rapidly 
in the ileum than jejunum (12). 
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Besides the columnar cells (enterocytes), w
hich are the most numerous, 
endocrine cells, mucous (Goblet) cells and 
Paneth cells are also found 
in intestinal mucosa, and all four cell typ
es are thought to arise from 
undifferentiated columnar stem cells at the
 base of the crypt (13). 
Mucous and endocrine cells also migrate up 
the villus, the latter 
having a longer turnover time than columnar
 cells (14). 
In general, cell turnover is similiar in the
 large bowel although more 
prolonged (four to eight days) than in sma
ll bowel (15), and as in 
small bowel, the columnar, mucous and endoc
rine cells of the colon, 
develop from stem cells at the base of the
 crypts (16). 
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THE PHENOMENA OF INTESTINAL ADAPTATION 
Just as the remaining kidney undergoes 'compen
satory hypertrophy' 
after contralateral nephrectomy (17) and the re
sidual liver compensates 
after partial' hepatectomy (18), so the small b
owel undergoes similiar 
adaptive changes after partial resection. This
 has been appreciated for 
some time, early studies noting these changes i
n the residual intestine 
after resection (1). The adaptive process is 
composed of a structural 
and functional component, 'and these are in turn
, the result of complex 
cellular changes. In addition, motility change
s occur, and these 
probably effect the absorptive capacity of the 
residual bowel. 
Structural changes 
At a macroscopic level, the residual bowel afte
r extensive enterectomy, 
shows compensatory dilatation. This was shown 
to be due to villus 
enlargement, and was initially termed 'villus h
ypertrophy' (1). 
However, it is now known that there is an incre
ase in enterocyte number, 
not size, and this process is thus a true hype
rplasia. In man, 22% 
increase in the number of epithelial cells per
 unit length of mid-
villus has been demonstrated after massive dist
al small bowel resection 
(19). This has been shown in dogs, where villu
s enlargement is due to 
hyperplasia after resection, manifest by an in
crease of cells/10 
microscopic fields, these changes being more p
ronounced in ileum 
than jejunum (20). Other animal studies (21,2
2) have confirmed hyper-
plasia rather than hypertrophy as the cause for
 the villus enlargement 
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after intestinal resection, and this has been shown biochemical
ly in 
bypassed rat intestine (23) where there is an increase in DNA/cm
 in the 
bowel in continuity, and after resection where there is an unalt
ered 
RNA/DNA ratio in the residual bowel (24), both indicating hyperp
lasia. 
Hyperplasia, the cause of the increase in villus height, is it
self 
a result of an increase in cell turnover. The term 'cell turnov
er', 
embraces all aspects of cell renewal, including replication in t
he 
crypts, migration up the villus, and extrusion at the tip of the
 villus. 
Thus 'turnover time' is the time taken to replace a number of e
pithelial 
cells, equal to that in the entire population (7,8). It has bee
n shown 
by autogradiography, 2 months after small bowel resection in the
 rat, 
that there is an increased migration rate, a shorter crypt trans
it time, 
and a shorter cell turnover time in the residual intestine, and 
that 
this increase in the rate of cell renewal amounted to 141% in th
e ileum, 
114% in the jejunum and 23% in the duodenum compared with contro
l segments 
(25). The cell migration rate increased to l~m/hour in this stu
dy 
(normal= !frm/hour) and this has also been shown after intestina
l bypass 
in rats (26). In the latter study, although an increase in migr
ation rate 
of cells up the villus was shown, no change in cell turnover co
uld be 
demonstrated. This would suggest that in the initial period of 
adaptation, 
although there is an increase in cell turnover, once an enlarged
 villus 
has been produced, a new steady state is achieved in which the
 duration 
of cell turnover reverts to its previous level, and villus heigh
t is 
maintained by accelerated cell migration (27). An increased rat
e of cell 
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division and a shorter cell cycle time has been demonstra
ted by auto-
radiography after intraperitoneal 
3 HTdR, in residual bowel after 10% 
ileal resection in rats (28). The shorter cell cycle is 
brought about 
predominantly by a reduction in the S phase of the cycle 
(21). 
Thus, as the migrating epithelial cells govern the size a
nd shape of 
the villus (29), the end result of the observed changes i
n cell 
turnover in the residual intestine after intestinal resec
tion, 
is villus enlargement (1,21,22,25,27,28,29). This is als
o true of 
the bowel in continuity after intestinal bypass (26,27,30
,31), and by 
the same token, a decrease in villus height has been dem
onstrated in 
the bypassed segment of bowel (26). 
Functional changes 
The adaptation of the intestine in terms of the functiona
l capacity of 
the absorptive epithelium, has been investigated measurin
g both mucosal 
enzymes and actual absorptive function. 
While the lipid esterifying enzymes, fatty acid CoA lipas
e and acyl-CoA 
monoglyceride acyl transferase, in residual ileal mucosa 
after jejun-
ectomy in rats is markedly increased per unit length of 
intestine (32), 
enzyme specific activity (enzyme levels per mg. of protei
n or per mg. of 
DNA) such as disaccheridase-specific activity, is unchang
ed, or reduced, 
as occurs with lactase activity (33). Similiarly, isolate
d epithelial 
cells from animals having undergone resection, showed an 
actual reduction 
in specific activity of disaccharidases (34). These find
ings suggest 
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immaturity of the cells within the hyperplastic mucosa,which is to be 
expected, due to the more rapid cell migration and turnover produced 
by partial resection. Similar findings have been found in enteric 
bypass in the rat (23) where enzymic activity per unit length of bowel 
is increased in the functional segment and reduced in the bypassed 
segment, while enzyme specific activity was diminished in the gut in-
continuity and increased in the bypassed segment. 
Studies on absorption in intestinal adaptation, follow a similiar pattern 
to mucosal enzyme measurements. Thus, while there is an increase in 
glucose, water and electrolyte absorption per unit length of intestine 
after resect:bn inman (35) and the rat (36), per unit cell, the uptake of 
monosaccharides and amino acids is unchanged (37) or diminished (34). 
Similiarly, B12 absorption is increased in the guinea pig after jejunal 
resection, but when this is measured per unit cell, a decreased absorption 
is demonstrated (38). Similiar changes have been shown for bile acid 
absorption in the rat (39). 
Thus, because of the more rapid cell migration and turnover in intestinal 
mucosa after resection or bypass, the villus is populated by functionally 
immature cells, and function per unit cell is consequently reduced. 
However, because of the hyperplasia which results, the net absorption 
per unit length is increased in the adapted bowel. 
Changes in bowel motility 
The increase in absorption per unit length of intestine during adaptation 
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is brought about by mucosal hyperplasia. However, an alternative 
mechanism of compensation might be a change of motility of the bowel, 
allowing a longer period of contact between the food and mucosa, thus 
enhancing absorption. 
Using radioactive chromate as a marker, intestinal transit was measured 
in rats after 50% and 75% proximal and distal small bowel resections (40). 
A decrease in intestinal motility was found, and this was more pronounced 
after proximal than distal resection. There was also a delay in gastric 
emptying. These changes were maximal in the second post-operative week, 
and thereafter returned to normal. 
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THE MECHANISMS OF INTESTINAL ADAPTATION 
While the changes, both structural and functional, which comprise the 
adaptive response have been fully illucidated, the mechanism by which 
this adaptation is initiated and maintained, are still under active 
investigation. No one single putative mechanism can account for all 
the changes seen in adaptation, and it seems likely that the pathogenes-
is is multifactorial. To date, three major and some minor influences 
have been proposed, and it is likely that a degree of interdependence 
exists between these. The major influences are luminal nutrition, 
pancreatico-biliary secretions and humeral factors, while changes in 
mucosa! blood flow, bacterial content and neural factors have been 
investigated to a lesser extent, and may be regarded as minor influences 
in the promotion of adaptation. 
A) LUMINAL NUTRITION 
Under normal circumstances most of the ingested nutrients are absorbed 
in the proximal small bowel, and the chyme reaching the ileum contains 
little if any nutrition. Evidence for luminal nutrition being important 
in influencing cell turnover, villus morphology and absorptive capacity 
of the small bowel, is derived from experimental studies in which segments 
of bowel are exposed to increased nutrition by proximal resection, trans-
position of segments, or hyperphagia, or deprived of it by bypass operations 
or by starvation or parenteral nutrition. 
- 14 -
After proximal small bowel resection, marked hyperplasia and a more 
rapid cell turnover is seen in the residual small bowel (21,36,41, 
42,43). Here the ileum receives a relatively greater nutrient load 
than normal, and increases its absorptive capacity to jejunal levels. 
That this is not due to a shortened bowel per se, and thus loss of 
absorptive surface area, is shown by ileojejunal transposition experi-
ments (36,44). When the positions of the ileum and jejunum are inter-
changed, the ileum again receives a greater amount of luminal nutrition 
than usual, and develops hyperplastic changes. Nor are these adaptive 
changes due to work hypertrophy secondary to a relative increase in 
luminal bulk, for when the bulk of the diet in rats was increased by 
80% with added kaolin, no change in small bOwel structure was found 
(45). Further support for luminal nutrition as a promoter of the 
adaptive hyperplasia, is derived from the finding that the intensity of 
the adaptive response is directly proportional to the length of 
intestine resected (42,43) and that proximal resection causes more 
pronounced adaptive changes than an equivalent distal resection (43). 
Furthermore, the amount of nutritional intake influences cell turnover, 
as hyperphagia produced by a number of experimental models (46,47,48, 
49,50,51,52) results in villus hyperplasia, increased mucosal thickness 
and enhanced absorptive capacity. 
Thus it seems that luminal nutrition in the above models, stimulates 
adaptive hyperplasia, by coming into contact with mucosa that normally 
is unaccustomed to chyme containing such high levels of nutrients. 
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Similar changes occur in the bowel in continuity after proximal small 
bowel bypass procedures (23,26), for the same reasons. Further support 
for luminal nutrition as a promoter of the adaptive response, is 
derived from experiments depriving the bowel of nutrients. 
During starvation (53,54), mucosal hypoplastic changes occur, and these 
are reversed by refeeding (54), However, this model produces malnutrition 
and it is difficult to know whether this or the lack of luminal nutrition 
is responsible for the mucosal changes. It is thus important to maintain 
nutrition of the experimental animal, and this can be done by employing 
Thiry-Vella bypass loops of the jejunum (55,56,57) or self emptying blind 
loops of jejunum (26,58). In both these models, hypoplastic changes 
occur in the bowel excluded from the nutrient stream. In the ileo-
jejunal transposition experiments (36,44), the ileum receives more 
luminal nutrition and develops hyperplastic changes, but the jejunum, 
now lying downstream and receiving chyme with less nutrition after ileal 
(proximal) absorption, undergoes hypoplasia. Total parenteral nutrition 
(TPN) provides another model for studying intestinal changes due to 
deprivation of luminal nutrients, without producing malnutrition. 
Parenterally fed rats with intact intestines (59,60) show a decrease in 
small bowel weight and loss of mucosal DNA, despite an increase in body 
weight. Similiar changes are found in the dog with an intact bowel 
(61) and after 50% proximal small bowel resection (62) where, in orally 
fed animals, the expected ileal adaptive hyperplasia was found, while in 
parenterally fed dogs, no such changes occured. 
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Additional evidence for luminal nutrition as a promoter of adaptation, 
is derived from experiments where direct stimulation by luminal nutrients 
occurs, of intestinal mucosa previously excluded from the nutrient 
stream, Thus refeeding after starvation (54) and restoration of intest-
inal continuity after intestinal bypass (58,63) completely reverses the 
hypoplastic changes caused by luminal nutrient deprivation. Direct 
perfusion of isolated Thiry-Vella fistulae in dogs (64) with saline 
prevented villus hypoplasia, while instillation of the elemental diet 
'Vivonex', not only prevented the hypoplasia, but induced hyperplasia. 
Similarly, infusion of glucose and amino acids with blind loops (65,66) 
prevents the hypoplasia and hypofunction caused by the bypass. Fat 
seems to be more potent stimulant than carbohydrates and protein as 
demonstrated by intragastric infusion of these nutrients in jejunect-
omized rats (67). 
There is therefore, much evidence to suggest that luminal nutrition 
plays a part in maintaining small intestinal mucosal structure and 
function, and also stimulates the adaptive response after resection or 
bypass procedures. The mechanism of action of luminal nutrition in 
this respect is at present hypothetical. A number of possibilities 
exist. These include direct action on the mucosa, stimulation of other 
enterotrophic factors such as pancreatico-biliary secretions or other 
regulators of tissue growth such as ornithine decarboxylase/diamine 
oxidase system (68). Neurovascular changes and alterations of luminal 
bacteria may occur secondary to alterations in luminal nutrition, and 
these in turn may have an affect on growth. Finally changes in gut 
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regulatory peptides are known to take place after small intestinal 
resection (69) and bypass (70), and it seems likely that some of 
these peptides may promote intestinal growth (see below). They are 
secreted by the APUD cells found in the intestinal mucosa. Some of 
these cells are of the 'open' variety, with microvilli connecting with 
the gut lumen and these microvilli act as chemoreceptors to luminal 
stimuli (71). It may thus be, that luminal nutrients may, in part, 
act by stimulating trophic hormones in the intestinal mucosa. 
B) PANCREATICO-BILIARY SECRETIONS (PBS) 
The various models discussed above viz: proximal small bowel resection, 
jejuno-ileal bypass, and ileojejunal transposition, not only expose 
the ileum to a richer nutrient stream, but also bring the ileum closer 
to higher concentrations of upper alimentary secretions, in particular 
bile and pancreatic juice (PBS). The oral intake of food stimulates 
the flow of bile and pancreatic juice. Thus in starvation and total 
parenteral nutrition, which causes pancreatic atrophy in rats (59) 
there are decreased amounts of these secretions. It has therefore been 
proposed that PBS may account for the intestinal hyper and hypoplasia 
seen in these models, and furthermore, that PBS are responsible for 
the fact that the villi in the duodenum are twice the size of the 
villi in the ileum, the so called 'villus size gradient' (44,72). 
Diverting the duodenal ampullary region into self-emptying loops of 
ileum (44,72) or into the middle part of the small bowel (73), produces 
distal hyperplasia, and furthermore, when the duodenal ampullary region 
is implanted into the mid-point of the intestinal remnant after 
jejunectomy (73,74), the ileal hyperplasia seen after proximal small 
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bowel resection, is significantly increased. Although differential 
implantation of biliary and pancreatic ducts suggests that pancreatic 
juice has the greater 'trophic' effect of the two (72), the maximal 
changes are found following exposure to combined PBS (73). In addition 
to the enhanced adaptive response that duodenal ampullary diversion 
has on jejunectomised rats (73,74) similar increased adaptive responses 
are found when this procedure is performed in cold-acclimated rats (75). 
To differentiate between the effects of luminal nutrition and pancreatic 
juice, or lack of these, on the small bowel mucosa, Hughes et al (61), 
administered iv CCK and secretin together, to a group of dogs on TPN, 
and compared this with a second group of dogs on TPN alone. The CCK 
and secretin, which stimulate the pancreas and bile flow, prevented 
the villus hypoplasia seen in the TPN group without added hormone 
administration, and similar studies in rats (76) confirm the 
above findings. This supported the hypothesis that PBS are trophic to 
the intestine. However, an alternative explanation is that CCK and 
secretin may have a direct trophic effect on the gut. This was studied 
further (77,78) by administraton of CCK-octapeptide (CCK-OP) alone, and 
of secretin alone in orally and parenterally fed rats, and no direct 
tropic effect on the gut by these hormones was found although CCK-OP 
clearly was trophic to the pancreas. The discrepancy between the dog 
and rat experiments could be related to species specificity, differences 
in method of administration (bolus in the dog experiments and continuous 
infusion in the rats), differences in CCK preparations, or possibly 
the fact that the hormones have to be given together to exert their 
enterotrophic effect. Indeed a potentiating effect of CCK and secretin 
on pancreatic bicarbonate and water secretion is established (79). 
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On balance, neither CCK nor secretin alone seem to have any major 
direct effect on intestinal adaptation. 
Further support for PBS having a trophic effect on small intestine, 
is derived from experiments where pooled, pre-harvested pancreatic 
juice was perfused into isolated intestinal loops, producing a modest 
degree of ileal adaptation (72,80). 
Recent studies, however, using pancreatico-biliary diversion (PBD), 
have produced results contrary to those expected, assuming that PBS 
are trophic to the intestine. In this model (81), the proximal 50 cm 
of small bowel is transposed to lie between the stomach and duodenum, 
thus depriving the jejunum of PBS. Rats with PBD were nourished either 
orally or with TPN, and results in each of these groups, were compared 
with control animals having intestinal transection only either nourish-
ed orally or on TPN. Assuming that PBS are trophic to the small intest-
ine and are responsible for the proximal to distal gradient in villus 
size (72) one would expect to find hypoplastic changes in the jejunum, 
now deprived of PBS after PBD. However, exactly the reverse occurred. 
While the ileum, now lying immediately downstream from the duodenal 
ampullary region after PBD, showed modest but significant increases in 
structure and segmental function, the jejunum, deprived of PBS after 
PBD, surprisingly showed hyperplasia with increase in villus height, 
mucosal mass and absorptive capacity. These experimental results do not 
support the hypothesis of PBS being trophic to the intestine, and indeed, 
the authors have suggested that they may inhibit intestinal mucosal growth, 
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the results seen in PBD being due to removal of this inhibitory effect, 
although this would not explain the modest hyperplastic changes seen in 
the ileum. Other explanations are that the changes in the jejunum after 
PBD may be due to other secretions such as gastric juice or epidermal 
growth factor (82,83) neurovascular changes or possibly humoral factors 
(see below). Indeed, plasma levels of enteroglucagon after PBD, are 
raised (84) and this peptide may in part, be responsible for the changes 
seen in PBD (see below). 
C) HUMORAL/HORMONAL FACTORS 
Luminal nutrition and PBS, cannot account for all the changes taking 
place in intestinal adaptation, and it is partly for this reason, 
that humoral or hormonal factors have been proposed as one of the 
putative mechanisms in the adaptation process. This partly negative 
circumstantial evidence is reinforced by more positive data, and in 
our present state of knowledge, it seems highly likely that humoral 
factors are important as a mechanism in intestinal adaptation. 
The circumstantial evidence, which does not negate the luminal nutrition 
and PBS hypothesis, is derived from the following:-
i) Adaptive hyperplasia occurs rapidly (24 to 48 hrs) and extensively 
after resection and transection of small bowel (85) before the 
animals are eating normally, and this 'anticipatory' adaptation, 
suggests that factors other than luminal nutrition, possibly 
humoral, may be operative. 
ii) Jejunal transection and re-anastamosis, causes transient hyperplasia 
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maximally around the anastomosis, but also extending to ileal 
mucosa (43), and this cannot be explained on the basis of 
luminal nutrition, or PBS. 
iii) After total colectomy in man (86) and the rat (87), the ileum 
undergoes adaptive changes, despite the fact that there is no 
change in nutrition or PBS reaching this part of the intestine. 
Similarly, after ileal resection, jejunal adaptation takes place 
(36,42). In both these models, factors other than luminal 
nutrition and PBS must be operative. 
iv) The fact that the adaptive changes after resection are diffuse, 
involving the bowel above and below the anastomosis (28,43), 
the muscle layer as well as the mucosa (43), and that gastro-
intestinal motility and transit are altered (40), points to a 
systemic factor involved in this process. 
v) After creation of defunctioned segments of ileum the normal hypo-
plastic changes in these isolated segments of bowel are reduced, 
with the production of biochemical and morphologic evidence of 
mucosal hyperplasia, by partial resection of the intestine in 
continuity, suggesting that both luminal and systemic factors 
account for these findings, with luminal nutrition perhaps being 
responsible for releasing an enterotropic factor from the bowel 
in continuity, which in turn, passes via the intact circulation 
to the isolated bowel, to bring about the limited hyperplasia 
seen in these loops devoid of luminal nutrition and PBS. In 
support of this, is the fact that atrophic changes develop in 
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isolated loops of·bowel when food given by mouth. is withdrawn 
(91). Similar findings in bypassed Thiry-Vella jejunal loops 
in lactating rats occur (92), where there are adaptive changes 
in the isolated loops, and it seems that an endocrine influence 
is operative in this model. 
vi) As mentioned before, the finding of jejunal hyperplasia after pan-
creatico-biliary division (PBD) (81), certainly does not support 
the hypothesis of PBS as a trophic factor, and as similiar results 
were obtained after both oral and parenteral nutrition, luminal 
nutrition cannot be held responsible for these changes. Other 
intraluminal factors, such as epidermal growth factor (82,83) 
may be important in this model, but humoral factors must be 
considered, and the finding of raised circulating enteroglucagon 
levels in PBD (84), supports this assumption. 
More direct evidence for the release of an enterotrophic hormone follow-
ing intestinal surgery, is found in a number of cross-circulation ex-
periments. Williamson et al (93) linked pairs of rats in free-running 
vascular parabiosis, with cannulae connecting carotid artery to jugular 
vein and vice versa. The dominant rat had either no operation, jejunal 
transection or jejunal resection, while the responding partner had no 
abdominal operation. Although the intact parabicnts did not show an 
increase of RNA and DNA, as did the transected and resected partners, 
there was marked and similiar elevations (>60%) in total and specific 
radioactivity in both the dominant and responding members of transection 
and resection pairs, implicating a transmissible factor in the adaptive 
response, although the above findings suggest that the transmitted 
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response was weaker than the direct response, suggesting that both 
systemic and local factors appear to be involved. Two similiar 
studies using cutaneous parabiosis (94,95), support the above data, 
although this is not a uniform finding (96), and it may be that 
intermingling of blood in the latter model could have been inadequate 
to detect an enterotropic factor. 
It seems likely that a systemic enterotropic factor or factors, con-
tribute to the initiation and/or maintenance of the adaptive changes 
which occur in the shortened bowel. Furthermore, it seems likely 
that the other major factors, luminal nutrition and PBS, probably act 
in concert with hormonal factors, and that much of the data quoted 
above, suggsts a unifying concept for the several mechanisms that 
govern intestinal adaptation. The APUD cells in the intestinal mucosa 
which secrete the gut hormones, some of which have been proposed as 
candidates for an enterotropic hormone, may be of the 'open' variety 
(71) and are stimulated by luminal contents via their microvilli, which 
act as chemoreceptors. It seems likely, that luminal nutrition and 
secretions trigger the release of these enterotropic hormones by this 
mechanism. Thus, total parenteral nutrition prevents the development 
of post-resectional hyperplasia, (59,60,61,62) not only by loss of 
nutrition within the lumen, but probably also by reducing PBS and APUD 
cell stimulation and thus hormonal release. Similiar changes occur in 
starvation (53,54), probably for the same reasons. Indeed a positive 
relationship between the amount of food ingested, the degree of ileal 
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TABLE 1.1 




4. Cholecystokinin (CCK). 
5. Corticosteroids. 
6. Prolactin and placental lactogen. 
7. Epidermal growth factor (EGF) and ornithine decarboxylase. 
8. Other hormones (pituitary hormones, testosterone, thyroxin, VIP). 
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hyperplasia, and the plasma level of one of the candidate hormones, 
enteroglucagon, after small bowel transection and resection has been 
demonstrated (97). While Thiry-Vella loops of bowel undergo limited 
hyperplasia following jejunectomy (89), when food is withheld by mouth, 
further atrophic changes develop in these'isolated loops of bowel (91, 
98). Similarly, in parabiotic rats (99), the hyperplastic changes in 
the unoperated parabiont, are prevented by starvation. 
Thus it seems likely, that enterotropic factors influence cell turnover 
in the bowel, and these hormones are in turn, affected by changes in 
luminal nutrition and secretions. These hormones may act systemically 
or locally, in a paracrine fashion. The fact that the hyperplasia 
after resection is more intense in the bowel in continuity than in 
bypassed segments (89) suggest that the latter mode of action is likely. 
A number of possible candidate humoral agents have been investigated. 
These are listed in Table 1:1. 
1) Gastrin 
Raised serum gastrin levels have been observed following intestinal 
resection in man (100), dog (101) and rat (102), and Johnson has 
claimed that this hormone may be important in intestinal mucosal 
growth (103). While the trophic effect of gastrin on parts of the 
gastrointestinal tract seems well established, its relationship to 
small intestinal mucosa! growth, is controversial. Small bowel 
mucosa! hyperplasia has not been recorded in other conditions where 
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hypergastrinaemia occurs, such as pernicious anaemia, the Zollinger-
Ellison syndrome, and antral G-cell hyperplasia. 
Studies, administering pentagastrin and observing its effect on small 
intestinal proliferation have produced conflicting results. While 
Pansu et al (104) showed that a single injection of pentagastrin 
caused proliferative activity of small intestinal mucosa to stay at 
nocturnal peaks for up to 24 hours, Mayston et al (lQS) found that 
pentagastrin injection into rats for 15 days, increased the weight 
and villus height only of the proximal duodenum, but not of the distal 
duodenum and jejunum. Furthermore, while atrophy of the small intest-
ine during parenteral feeding could be prevented by pentagastrin infusion 
(106), this could not be confirmed when rats, having had 50% small 
intestinal resection, were fed parenterally, with or without pentagastrin 
infusion (107). Pentagastrin in this study (107) was able to cause a 
significant increase in mucosal weight, protein and DNA content, only 
in the proximal part of the small intestine. Additional evidence against 
gastrin as a trophic hormone to the small intestine, is derived from 
the fact that antrectomy has no effect on the growth of the middle region 
of the small bowel, nor on its adaptive response to partial intestinal 
resection (108). Furthermore, no correlation could be found between 
crypt-cell production rate in the terminal ileum and circulating gastrin 
levels, in a number of different models of intestinal adaptation (109}. 
The effect of luminal gastrin has also been investigated (110). While 
gastrin infused into the ileum has trophic effects, no such changes on 
the ileum could be demonstrated when gastrin is infused into the stomach, 
its normal site of release. 
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Gastrin does appear to have a regulating effect on growth of the 
stomach, duodenum, colon and pancreas (103,111,112,113). The effect 
of gastrin on the stomach appears to be confined to the oxyntic gland 
area, and does not effect the gastric antrum (106). Thus, penta-
gastrin administered to rats undergdng parenteral nutrition, prevented 
the decrease in weight of the oxyntic gland area, but had not affect 
on the antrum. Similiarly, admimistration of tetragastrin to starving 
rats, prevented the loss of DNA from the oxyntic gland area (114). This 
trophic effect of gastrin on the oxyntic area of the stomach, has been 
shown to be independent of acid secretion (115), but can be blocked by 
simultaneous administration of secretion (115,116). 
Gastrin has also been shown to have a trophic effect on fundic but not 
antral mucosa in the dog (117) and man (118). Furthermore, marked hyper-
plasia of gastric mucosa is found in cases of the Zollinger-Ellison 
syndrome (119). 
Gastrin also has a trophic effect on duodenal mucosa. Thus, penta-
gastrin given for 15 days, increased the duodenal weight in rats (120) 
and also has an effect on the doubling time of duodenal mucosal cells 
in vitro (121). Gastrin is also thought to have a trophic effect on 
colonic mucosa. Thus, while rats having either resection of 50 ems of 
distal small bowel alone, or resection plus antrectomy, showed no 
difference in DNA content of the proximal and distal ileum between the 
two groups, there was a significant fall in DNA content in the colon, 
in the resection plus antrectomy group, compared to rats having resection 
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alone (110). This is supported by infusion studies of pentagastrin (111). 
Thus, while it seems likely that gastrin has an established role as a 
trophic hormone to the mucosa of the oxyntic gland region of the stomach, 
duodenum, colon, ~nd the exocrine pancreas (122), its possible trophic 
role on the small bowel, remains unlikely. 
2) Enteroglucagon: 
This gastrointestinal peptide .has been investigated as a possible entero-
tropic hormone, and numerous reports have shown an association between 
plasma levels of immunoreactive enteroglucagon and situations, both 
naturally-occurring and experimental, in which intestinal adaptation 
is known to occur. Indeed, so close is this correlation, that entero-
glucagon has been proposed as the 'growth hormone to the small intestine' 
( 123 ) • 
In 1971, Gleeson et al (124) reported a patient with an enteroglucagon 
producing renal tumour. The patient had gross small bowel dilatation, 
mucosal thickening, with marked villus enlargement, which was visible 
naked eye. There was also a markedly raised plasma enterglucagon level. 
In addition to the structural changes, there was also delayed gastro-
intestinal transit, as suggested by constipation and delayed transit on 
barium studies. After removal of the tumour, the plasma enteroglucagon 
levels returned to normal. There was a marked change in the clinical 
picture, with the patient's constipation disappearing almost immediately. 
Barium studies now showed that there was rapid intestinal transit and 
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previous dilatation of the small bowel had returned to normal. Per-
oral jejunal biopsy showed that the gross villus hyperplasia had 
reverted to normal. The immunoassay and bioassay characteristics of 
the tumour, showed that this was indeed producing enteroglucagon 
(125). Furthermore, when saline extracts of the tumour were injected 
intraperitoneally into mice, obvious enlargement of the small bowel 
occurred (126). The idea was thus born, that enteroglucagon may have 
been the trophic factor responsible. 
In 1959, Unger et al, described a radioimmunoassay (RIA) for glucagon 
(127) and it soon became apparent that this RIA was not specific for 
pancreatic glucagon. The anti-glucagon sera available, was shown to 
cross react with extracts from the small intestine of many animals. 
However, when a more specific assay for pancreatic glucagon was devel-
oped, this detected only the pancreatic but not the intestinal peptide. 
This demonstrated that the two peptides were not identical, and the 
name enteroglucagon was coined for the intestinal peptide. Although 
this name is still most frequently used, other terms such as gut 
glucagon cross-reacting material,gut glucagon, gut glucagon-like 
immurioreactivities, and glucagon-like immunoreactants (gut GLI), have 
also been proposed to describe this peptide. The complete amino acid 
sequence of porcine enteroglucagon (glicentin) has been published (128) 
(Fig. 1.2), and it is apparent that the reason for the cross reaction 
between the intestinal and pancreatic peptides, is that the sequence 
33-61 of enteroglucagon is the complete sequence of pancreatic glucagon. 
Antisera directed towards the N-terminal portion of pancreatic glucagon 
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also detects enteroglucagon, while those directed towards the C terminal 
portion of the pancreatic glucagon molecule, do not, and it has been 
suggested that this can be explained by the tertiary folding of entero-
glucagon which in some way covers the C terminal portion, but not the 
N terminal portion of the included pancreatic glucagon sequence (129). 
Furthermore, amino acids 62-69 in the enteroglucagon sequence, are 
virtually identical with the previous C terminal extension peptide, 
which was thought to be part of the sequence of pancreatic pro-glucagon, 
and it has been suggested that the gene coding for pancreatic glucagon 
and porcine glicentin, and thus the precursor peptide first synthesised, 
is identical, the two cell types differing only in their post-trans-
lational enzyme processing (71,130). Thus, enzymes in the pancreatic 
alpha cell, splits the parent molecule, to release the glucagon 
sequence. This hypothesis is supported by the facts that positions 
31-32 and 62-63 of the enteroglucagon molecule, are double basic amino 
acids, which is a combination particularly favoured for attack by proteo-
lytic enzymes of the trypsin class, and that the alpha cell of the 
pancreas, and enteroglucagon cell (EG cell) of the intestine, have very 
similar histological appearances (129). Furthermore, it has been 
reported that the core of the granule of the alpha cell contains 
pancreatic glucagon, while the less dense halo contains the N-terminal 
fragment of porcine glicentin (131,132). Additional morphologic support 
comes from studies in which sections of ileal mucosa were subjected 
to enzymatic digestion with trypsin and carboxypeptidase B, whereby 
the glicentin-storing EG-cells exposed the C-terminal glucagon immuno-
determinant (133). Although chromatographic analysis shows entero-
glucagon immunoreactivity to be present in several molecular-sized 
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peaks, it seems likely that this isa single hormone molecular family, 
and not several different cross-reacting hormonal systems, as was 
first suggested (71). There are, unfortunately considerable species 
differences, and antisera raised to porcine glicentin, does not react 
with human enteroglucagon. Furthermore, only minute amounts of porcine 
material have thus far been purified and although an inhibition of gas-
tric acid secretion by this peptide has been demonstrated (12A), 
studies related to its direct effect on enterocyte turnover are still 
awaited. 
The distribution of the enteroglucagon (EG) cells in the bowel, and the 
factors controlling secretion of this hormone, are of importance in 
appreciating the changes in enteroglucagon seen in many pathological 
and experimental situations. The enteroglucagon (EG) producing cells 
have a distal distribution in the gut. The greatest concentrations are 
found in the distal ileum, with a lesser but still significant con-
centration found in the colon (135). These EG cells are long, flask-
shaped cells, reaching from the basal membrane to the intestinal lumen, 
where microvilli protrude into the lumen (71,129,136), and it is thought 
that these microvilli act as chemoreceptors or cell 'sensors' to luminal 
stimuli. Indeed, the major stimuli for the production of enteroglucagon, 
are carbohydrates (eg glucose) and digested fat (eg long chain fatty acids) 
(137,138). In situations where luminal nutrients are not absorbed in 
the upper small bowel, either following surgery to this part of the gut, 
or in various malabsorption states, the enteroglucagon producing distal 
intestinal mucosa is exposed to abnormally rich chyme, which leads to an 
exaggerated secretion of enteroglucagon, and it has been postulated that 
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this peptide may be responsible, at least in part, for the adaptive 
hyperplasia and increased enterocyte turnover found in these situations 
(70,71). Although hypertonic glucose solutions provide a strong 
stimulus to enteroglucagon release, it seems to be the amount of 
glucose presented to the mucosa, rather than the tonicity which deter-
mines the strength of the stimulus (71). Indeed, this has been con-
firmed in experimental models of adaptation, where the greatest plasma 
levels of enteroglucagon and the greatest rates of crypt cell production, 
were found in hyperphagic animals, while the lowest hormone and cell 
production levels were found with parenteral nutrition (97). Further-
more, it has been shown that long chain triglycerides (LCT) given 
intragastrically, promote small bowel adaptation following resection, 
and in this respect, the quantity of LCT seems to be important (67). 
It has been speculated, that these effects may be due to the release 
of enteroglucagon (67). The EG cell is not responsive to hypoglycaemia 
(as is the pancreatic alpha cell (139)) and intravenous administration 
of nutrients, such as carbohydrates and lipids, is ineffective (137). 
Thus it seems that the luminal route of stimulation is the most import-
ant. However, bombesin and gastrin-releasing peptide (GRP) both stimul-
ate enteroglucagon (140,141) while somatostatin inhibits luminally 
stimulated secretion (142). These findings suggest that local pepti-
dergic control may play a part in enteroglucagon secretion. 
Besides evidence derived from the case of the enteroglucagon producing 
tumour (124,125), enteroglucagon is found to be significantly elevated 
in the plasma, in many clinical situations where intestinal adaptation 
occurs. The underlying mechanism of this hypersecretion, appears to be 
- 34 -
abnormal and excessive exposure of the distal intestinal mucosa (the 
predominant site of production of enteroglucagon) to unabsorbed 
nutrients. Thus in coeliac disease, which affects only the upper 
small intestine, enteroglucagon is found to be markedly elevated 
(143,144). This contrasts to normal enteroglucagon levels in patients 
with coeliac disease treated with a gluten-free diet (143). Enterocyte 
turnover is known to be increased in coeliac disease, but not in 
patients successfully treated with a gluten-free diet. Similiarly, 
enteroglucagon levels are raised in tropical malabsorption (145), and 
the degree of elevation of enteroglucagon correlates closely with 
breath hydrogen, which reflects the degree of functional malabsorption 
of carbohydrate in the small intestine, and its consequential metabolism 
by colonic bacteria. Enteroglucagon is also three-fold increased in 
acute infective diarrhoea (146). The same mechanism operates after 
various surgical procedures, giving rise to malabsorption in the upper 
small bowel. Elevated enteroglucagon levels, especially postprandially, 
are seen after total pancreatectomy (147). By the same token, patients 
with chronic pancreatitis and steattorrhoea, are found to have elevated 
enteroglucagon levels (148). After partial small bowel resection, which 
has the effect of exposing the distal intestinal mucosa to unabsorbed 
nutrients, enteroglucagon was approximately two-fold elevated in the 
basal state, and three-fold elevated after a meal (69). Jejunoileal 
bypass operations, done for morbid obesity, has the same effect on the 
distal intestinal mucosa, and despite significant weight loss, entero-
glucagon levels are greatly increased (70,149). After both small 
intestinal resections and bypass procedures, marked adaptive changes 
occur in the residual small bowel in continuity. Interestingly, after 
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colonic resections, a fall in enteroglucagon occurs (69). However, 
when it is appreciated that although the colon has approximately an 
eighth of the enteroglucagon concentration compared to the ileum, 
because of the greater weight of this region, the total amount of 
enteroglucagonisconsiderably larger than the ileum (136), and the 
finding of reduced enteroglucagon levels after colonic resection, 
is thus not unexpected. After gastric resection, the dumping syndrome 
may occur. This is associated with rapid intestinal transit, and is 
accompanied by raised enteroglucagon levels (150,151,152,153}. Indeed, 
a significant correlation between gastric emptying rate and entero-
glucagon secretion has been found in duodenal ulcer subjects (154). 
Thus in man, there is strong circumstantial evidence of an association 
of enteroglucagon and adaptive changes which occur in the situations 
discussed above. In addition to this, when healthy infants commence 
enteral feeding, there is a rise in most gastrointestinal hormones, 
including enteroglucagon (155), but no such rise is seen in infants 
who for various reasons, are kept on parenteral feeding (156). When 
infants commence oral feeding, there is rapid gut adaptation, and the 
organs increase in size significantly (136). Enteroglucagon, which 
shows the most dramatic change, may well be involved in this process. 
As in man, there is also in the experimental animal, much circumstantial 
evidence to suggest that enteroglucagon may be one of the trophic 
humoral factors involved in the adaptation process. Thus, in one study, 
tissue levels and fasting plasma levels of enteroglucagon were measured 
in rats after small bowel resection, during lactation, and when hyper-
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phagia was induced by hypothermia, all situations where intestinal 
adaptation is known to occur (157). After proximal two-thirds small 
bowel resection plasma and tissue enteroglucagon levels nearly doubled, 
during cold acclimation plasma levels tripled and tissue levels doubled, 
while on the 12th day of lactation, tissue enteroglucagon levels doubled, 
although plasma enteroglucagon did not change significantly. The number 
of enteroglucagon cells in this study were increased, while the cells 
also increased in size. The intensity of the adaptive hyperplastic 
response is known to be directly proportional to the length of small 
bowel resected (42,158), and the enteroglucagon concentrations have 
also been shown to be elevated in proportion to the amount of bowel 
resected (159). Changes in plasma enteroglucagon were also studied in 
rats undergoing 75% proximal small bowel resection, with the excluded 
bowel fashioned into a Thiry-Vella fistula (98). Half the animals 
were fed orally, while the remainder were nourished isocalorically 
by total parenteral nutrition. Plasma enteroglucagon was found to be 
much greater in oral than IV fed animals, while cell turnover jn the termjnal 
il~um in contjnuity, as measured by the crypt cell productjon rRte (CCPR) was 
greater in the oral compared with IV fed rats. The CCPR in the 
excluded Thiry-Vella fistula, although less than the CCPR in the bowel 
in continuity, was significantly greater in the orally fed compared with 
the IV fed group. This study, therefore, suggested that there is indeed 
a humeral agent affecting the CCPR, and that enteroglucagon may well be 
a candidate for this role. Gastrin was also measured in this study, 
but the changes in this peptide did not correlate with the adaptive 
changes. Besides the humeral mechanism, this study also underlined 
the importance of the nutrient stream, and it is likely that food in 
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the lumen, was responsible for the changes in enteroglucagon in the 
orally fed group, which were much reduced in the IV fed group. Luminal 
nutrition, in particular carbohydrates and long chain fatty acids, are 
known to be the major stimuli of the EG cells, and thus of enteroglucagon 
release (137,138). There appears to be a relationship between the amount 
of ingested nutrients, the CCPR and plasma enteroglucagon. Forty-eight 
rats were studied after either 75% proximal small bowel resection or 
jejunal transection (as controls)and the animals were divided into 3 
groups, the first of which was allowed food ad libitum, the second was 
kept hypothermic (resulting in hyperphagia) while the third group was 
nourished intravenously (97). The greatest plasma enteroglucagon and 
CCPR changes were found in the hyperphagic animals, while the lowest 
levels of these two parameters,were found in the TPN group. Gastrin was 
also measured in this study, and showed no significant changes. 
Long chain triglycerides, administered intragastrically, promotes 
adaptive hyperplasia after small bowel resection, and the extent of this 
adaptation is proportional to the amount of fat given (67). It has been 
suggested that this effect may be mediated via enteroglucagon release, 
although this peptide was not measured in the study. Bombesin is known 
to stimulate (140,141) and somatostatin to inhibit (142) enteroglucagon 
release. These two peptides were administered over a 7 day period to 
rats having small bowel resection and transection (160), and plasma 
enteroglucagon and CCPR were measured. After administration of somato-
statin, plasma enteroglucagon and CCPR fell in parallel, while bombesin had 
the effect of increasing these parameters after transection, although there 
was little effect in resected animal, where maximal adaptation had already taken 
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place. This further demonstrates that regulatory peptides can influence 
adaptation, but it is as yet not clear whether the effect of somato-
statin and bombesin is a direct one, or whether the changes in cell 
proliferation occurred indirectly, via changes in enteroglucagon 
Studies where the duodenal ampullary region is implanted into the mid 
small bowel, or into the intestinal remnant after jejunectomy, produce 
intestinal hyperplasia distal to the site of implantation, and intensifies 
the hyperplasia seen after resection (73,74). These studies, and others 
(44,72), have promoted the suggestion that pancreatico-biliary secretions 
(PBS) may have a trophic influence on small bowel mucosa. Plasma 
enteroglucagon and CCPR were measured in rats having intestinal resection 
or transresection, half of these animals having their ampullary region re-
implanted into the mid colon. While rats not having PBS diverted to the 
colon, had significantly greater hyperplastic changes in the ileum 
compared with animals having a diversion, plasma enteroglucagon levels 
were found to change in parallel to those of the CCPR (161). Likewise, 
after pancreatico-biliary diversion (PBD) in the rat (84), plasma 
enteroglucagon levels are high eight days after the procedure, and mucosal 
hyperplasia has become established. After three months, although intest-
inal mucosal hyperlasia was unchanged, plasma enteroglucagon levels had 
returned to normal levels, and it has been suggested that in this model, 
enteroglucagon may act as a 'trigger' mechanism, but may not necessarily 
be involved in maintaining the adaptive hyperplasia. Using various 
models of intestinal adaptation, a strong correlation was found between 
mucosal hyperplasia, as indicated by the crypt cell production rate, and 
plasma enteroglucagon levels (loq). Studies on the enteroglucagon (EG) 
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cell, have shown marked changes in response to an increased demand 
for hormone synthesis and release (162). Ultrastructural studies demon-
strate reduced hormone storage in the EG cells with a reduction in 
the number of secretory granules and immunocytochemistry shows an 
apparent decrease in enteroglucagon cell content in the mucosa of 
adapted animals after resection. These changes, coupled with high 
plasma enteroglucagon levels observed in these models, would indicate 
a functional hyperactivity of the enteroglucagon cells. Using a micro-
dissection technique and immunostaining, EG cells were found to be more 
numerous in the crypt region after 80% proximal small bowel resection, 
compared with control animals (136). 
Thus, there is strong circumstantial evidence, both in man and in the 
experimental situation, that enteroglucagon may be trophic to the intest-
inal mucosa. To date, a definite cause-and-effect relationship between 
enteroglucagon and intestinal mucosal growth has not been shown, although 
enteroglucagon remains a strong candidate for such a role. This has been 
re-inforced recently, by the finding that low dose, partially purified rat 
enteroglucagon produced a 50% increase in DNA synthesis in cultural guinea 
pig jejunal mucosal cells (163). 
3) Secretin: 
Secretin inhibits gastrin release, and may therefore be expected to have 
an antitrophic effect on parts of the stomach and duodenum. Indeed, 
the 90% increase in maximal acid output and 70% increase in the parietal 
cell population obtained when rats were injected daily with pentagastrin, 
was abolished when pentagastrin and secretin were injected together, and 
animals receiving only secretin, had slightly lower secretory capacities 
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and parietal cell counts, than saline injected controls (116). This 
effect of secretin is unlikely to be due to its acid inhibiting effect, 
as metiamide, a potent inhibitor of gastrin stimulated acid secretion 
has n-0 effect on the trophic influence of pentagastrin on the stomach 
and duodenum {164), and is more likely to be due to inhibition of 
trophism by suppression of endogenous gastrin (165). Secretin is thus 
unlikely to have a direct antitrophic effect on the stomach and upper 
duodenum (166). 
Conflicting evidence exists regarding the effect of secretin on the 
small intestine. Pharmacological doses of secretin administered to 
rats, increased the weight and DNA, sucrase and maltase content of the 
small intestine (167) suggesting that this peptide may have a trophic 
effect on this organ. Indeed, when mucosal structure and function was 
investigated in dogs, who had either total parenteral nutrition (TPN) 
alone, or TPN plus daily administration of CCK and secretin together, 
the CCK and secretin was found to prevent the villus hypoplasia of the 
group having TPN alone (61). The results of this study suggest that 
secretin and CCK produced their effect either directly on the gut, or 
via the stimulation of pancreatico-biliary secretions (PBS) which are 
thought to have a trophic influence. When, however, low and high doses 
of CCK and secretin were administered separately to orally and parenterally 
fed rats, no trophic effect on the gut was found (77,78). 
Thus it seems that secretin probably does not have a major direct trophic 
effect on the small bowel. 
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4) Cholecystokinin (CCK): 
CCK is structurally and functionally related to gastrin, with the 
active C-terminal tetrapeptide amide of gastrin, duplicated in CCK. 
The major structural difference is the position of the tyrosyl residue 
and whether or not it i,s sulphated. These differences appear to 
determine that gastrin has affinity for receptors stimulating acid 
secretion, while CCK has affinity for receptors lower down, ie the gall 
bladder, pancreas and possibly the small bowel (165). CCK has been 
shown to regulate pancreatic growth, as indicated by an increase in 
pancreatic weight (168), pancreatic DNA content {169), and an increase 
in pancreatic RNA, protein, DNA content with the stimulation of (14C) 
thymidine incorporation into DNA (170). These results have been inter-
preted as indicating that CCK is a trophic hormone to the pancreas. 
Regarding the intestine, CCK has been shown to cause an increase in 
duodenal but not gastric mucosal DNA synthesis (171), As mentioned 
above, CCK and secretin administered together, prevented the small 
bowel villus hypoplasia of TPN in dogs (61). When, however, secretin 
and CCK were administered separately to orally and parenterally fed rats, 
no trophic effect of these hormones could be found (77,78). 
Thus, although CCK is probably a physiologically important regulator 
of pancreatic growth, it is unlikely to have any major trophic influence 
on the gut. 
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5) Corticosteroids: 
The effect of glucocorticoids on the intestinal mucosa seems to be two-
fold, on the one hand stimulating enterocyte function, while on the 
other, reducin~ enterocyte production (172). Thus, prednisolone fed to 
rats for 7 days, had little effect on mucosal structure or cell kinetics, 
but enhanced the maximum absorptive capacities of the jejunum and ileum 
for P,alactose (173,174). This was due to an increase in carrier-mediat-
ed transport in the individual enterocytes and not to a change in cell 
population. Activities of brush border enzymes were elevated, and turn-
over studies indicated an increase in the rate of synthesis of brush 
border oroteins, associated with an enhanced glycoprotein content of the 
microvillus membrane (175). These findings suggest a direct action of 
prednisolone on the enterocytes to increase their absorptive and digestive 
capacities by the induction of specific functional proteins. When, 
however, prednisolone and betamethasone-17-valerate, a locally active 
glucocorticoid, were given for 28 days (176) there was mucosal hypo-
plasia, with an inhibition of cell turnover, in the betamethasone-17-
valerate group, but prednisolone had very little effect on jejunal 
mucosal structure. Both the steroids enhanced D-galactose absorption and 
the activities of brush border enzymes, although, as betamethasone-17-
valerate caused a reduction in enterocyte population, there was no change 
in absorption per centimetre compared to controls. Thus it would seem 
that glucocorticoids have separate and opposing actions on intestinal 
mucosa, ie. stimulating enterocyte function, and reducing enterocyte 
turnover, and the predominant activity appears to be a function of each 
individual steroid. 
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In the adapted bowel after proximal intestinal resection, prednisolone 
is capable of enhancing further the hyperplasia of the residual bowel, 
although there is no increase in the degree of hyperplasia. Prednisolone 
increases the functional capacity by enhancing the enzyme activities of 
the residual enterocytes, resulting in a further increase in brush border 
enzyme activities per centimetre (177). Using mucosa! explants, it has 
been shown in vitro, that dexamethasone induces sucrase and maltase 
enzyme activity (178). 
Thus it may be that corticosteroids, secreted in response to major 
intestinal resections, could well play a part in promoting functional and 
structural adaptation inthe residual intestine (17~) and this is supported 
by the finding of mucosa! atrophy found after adrenalectomy (180). 
6) Lactation: 
Small intestinal hyperplasia and hyperfunction occurs during lactation 
(47,48,92). While these changes may be related, in part, to the hyper-
phagia observed, these adaptive changes are not completely prevented oy 
restricting food intake to normal levels. This points to the possibility 
of a humoral agent responsible for these changes, and indeed, by-passed 
Thiry-Vella jejuna! loops fashioned in lactating rats, undergo comparable 
adaptive changes to those found in lactating animals with an intact 
intestine, despite being deprived of food and PBS, supporting this hypo-
thesis (92). Prolactin seemed a strong candidate for such a role. 
However, when hyperprolactinaemia was induced experimentally in rats by 
perphenazine injections and pituitary transplantation (181), no changes 
of adaptation in small bowel were observed. It therefore seems unlikely 
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that prolactin can be held responsible for these changes in lactation. 
Furthermore, the duodenal mucosal proliferation seen in lactation, has 
been shown to be unrelated to changes in gastrin levels (182). While 
prolactin and gastrin have been excluded as trophic hormones to the small 
bowel during lactation, ileal tissue enteroglucagon levels have been shown 
to double in lactating rats, although plasma enteroglucagon levels in 
this study did not change (157). Thus, enteroglucagon remains a candid-
ate for a trophic role on small bowel mucosa during lactation, although 
this requires further elucidation. 
7) Epidermal Growth Factor (EGF), and Ornithine Decarboxylase: 
EGF is a 53 amino acid polypeptide and has been shown to have biologic-
al activity on cell proliferation in the intestinal tract. It was 
isolated from mouse submandibular glands, and resembles urogastrone (183). 
It has also been shown to stimulate ornithine decarboxylase in the 
digestive tract (184). Ornithine is the starting substrate for the 
biosynthesis of the polyamines, putrescine, spermidine and spermine (68), 
and these polyamines in turn, have been shown in vitro, to facilitate 
nearly all aspects of DNA, RNA and protein synthesis (185,186). 
It has been shown that specific receptors for EGF exist in isolated 
rat intestinal epithelial cells (187). EGF, given intraperitoneally or 
intraluminally, stimulates gastroduodenal mucosal DNA synthesis in the 
rat (82), DNA synthesis in mouse duodenal and jejunal mucosa (188) and 
duoden~~ ileal and colonic crypt cell proliferation in rats and mice (189). 
Stimulation of salivary secretion by isoproterenol, produces an increase 
in nucleic-acid content of mucosal cells and villus height in mouse small 
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intestine (83), while anti-nerve growth factor (NGF), also contained in 
saliva, decreases villous epithelial cell renewal (190). 
Increased intestinal mucosal ornithine decarboxylase activity and increas-
ed polyamine content of intestinal mucosa in rats, has been found in the 
period of intestinal maturation up to 40 days after birth, during mucosal 
recovery after injury with arabinosyl cytosine, after jejunectomy and 
during lactation (68), all recognised models of intestinal adaptation. 
The adaptive processes during mucosal maturation and mucosal recovery 
after injury, were markedly delayed by administration of the ornithine 
decarboxylase inhibitor, o<'-difluoromethyl ornithine (DFMO), as was the 
ornithine decarboxylase and polyamine content of the mucosa (68). 
Thus, saliva, containing EGF, NGF or other trophic factors, may act via 
the intraluminal route directly, in a similiar fashion to luminal nutrition 
and PBS, or by stimulation of other known trophic agents, such as ornith-
ine decarboxylase (184). 
8) Other hormonal candidates: 
After hypophysectomy, marked hypoplastic changes occur in the intestine, 
although the reduced food intake associated with this procedure, may 
account for these intestinal changes. When hypophysectomy is combined 
with jejunal or ileal resection, the degree of adaptation is less than 
in pair-fed controls (191), suggesting that pituitary hormones may have 
a trophic influence on small bowel mucosa. Testosterone (192), growth 
hormone and thyroxine (193) may all influence mucosal growth, although 
thyroxine appears to exert its effect by hyperphagia (194). Small doses 
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of histamine and seratonin stimulate intestinal cell proliferation, 
while large doses are inhibitory (195). Vasoactive intestinal poly-
peptide (VIP) inhibits the trophic effect of pentagastrin on the 
gastrin mucosa, while glucagon stimulates DNA synthesis in both 
oxyntic gland mucosa and colon (103). The influence of drugs effecting 
the autonomic nervous system, are discussed under mucosa! blood flow and 
neural factors. 
D) MUCOSAL BLOOD FLOW 
After small bowel resection, there is an increase in ilea! mucosa! blood 
flow two days after the procedure, but this has returned to normal by two 
months (196). This initial increase in blood flow may be associated with 
adrenergic denervation of the residual small bowel (197). It is un-
certain to what extent the altered blood flow contributes to the adaptive 
mechanism, but certainly manipulation of blood flow experimentally can 
effect cellular proliferation. Alpha-adrenergic stimulation is known to 
increase intestinal mitotic activity and epithelial cell migration rate, 
while beta-adrenergic stimuli have the opposite effect. Thus infusion of 
noradrenaline, which is a vasoconstrictor, produces increased cellular 
proliferation, while~-adrenergic blockade has the reverse effect (198). 
Inhibition of mitotic activity occurs with adrenaline, and thjs js revers-
ed by p-adrener~ic hlockade (198). Deprjvatjon of the blood supply to 
produce te~norRry jntestjnal jschaemja, results jn hypoplasja, with 
s11hsPquent hyoernlasj a duri n.r: the rPcovery phase ( 199). 
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E) NEURAL FACTORS 
Manipulation of the autonomic nerves to the gut, have been shown to 
have, an effect on mucosal proliferation, but whether this is a direct 
action or via changes in the blood flow or possibly by producing local 
hormonal changes, either related to paracrine secretions, circulating 
hormones, or possibly by its effect on neurotransmittors of the peptid-
ergic system (135), is at present unclear. Thus, sympathectomy has an 
inhibitory effect on cell proliferation (198,200), and accentuates the 
mucosal hypoplasia in IV fed rats (201), although inhibition of prol-
iferation wasprevented by intragastric infusion of luminal nutrients. 
Electrical stimulation of mesenteric nerves results in an increase in the 
mitotic rate of intestinal crypts (202). The effect of changes of sym-
pathetic tone on mucosal cell proliferation, produced either by chemical, 
surgical or immune means, is not surprising, as histochemical studies 
have revealed an abundant adrenergic innervation at the base of the 
crypts of Lieberkuhn which may be involved in the regulation of crypt 
cell turnover (203). 
Vagotomy causes mucosal hypoplasia throughout the small intestine (204, 
205,206). When the afferent or sensory fibres of the vagus in the pig 
are divided, there is an inhibition of the adaptive response to jejunect-
omy (207), and it has been suggested that these sensory vagal nerves, may 
act as the afferent pathway for signals from the residual intestine after 
enterectomy, to the hypothalamo-hypophyseal axis, thus triggering the 
humoral response (208), in keeping with the hypothesis of functional demand 
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(209), to explain the adaptive changes. 
F) GUT BACTERIAL FLORA 
Although germ free rodents have reduced rates of cellular turnover in 
the intestinal mucosa (210,211), instillation of bacterial suspen-
sions into isolated intestinal loops, fails to produce an increase in 
cellular proliferation (212). The extent to which changes in bacter-
ial flora play a part in intestinal adaptation is uncertain, but these 
changes do not appear to be a major factor. 
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C H A P T E R 2 
T H E PURPOSE, A I M S A N D 0 U T L I N E 
0 F T H E E X P E R I M E N T A L S T U D I E S 
The mechanisms governing the adaptive process of the intestine during 
disease or after surgical manipulation, appear to be multifactorial and 
probably interrelated. Although luminal nutrjtjon and pancreatjco-bjljary secret-
ions {PBS) have been most extensively investigated and are important, they 
cannot account for all the aspects of the adaptive response, and systemic 
factors are also likely to be operative. Gastrin was proposed for such a 
role (103), and following the publication of a case report of a patient 
with an enteroglucagon producing tumour (124,125), and the findings of 
raised plasma enteroglucagon levels in a number of gastrointestinal 
conditions in which intestinal adaptation is known to occur (129), inter-
est has been directed to this peptide, as a possible 'enterotrophin'. 
The purpose of the work to be described, was to investigate further the 
role of humoral factors in the adaptive process of the small intestine, 
and as enteroglucagon and gastrin seemed to be the main candidates for 
a trophic role, these two peptides were studied. 
The aims of the studies were to determine: 
a) the extent to which luminal nutrition and pancreatico-biliary 
secretions (PBS) contribute to the mechanism of adaptation after 
small bowel resection, jejuno-ileal bypass and total colectomy. 
b) whether systemic or hormonal factors participate in this process, 
and if so, their relationship to oral nutrition and PBS. 
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c) whether specific gastrointestinal hormones can affect cellular 
proliferation in small bowel. 
d) the part played by the two main candidate trophic hormones, gastrin 
and enteroglucagon, in the adaptive process. 
e) whether enteroglucagon is capable of initiating and maintaining 
these adaptive changes after intestinal resection. 
f) the mode of release of enteroglucagon during adaptation, and the 
relationship between this peptide and luminal nutrition in the 
context of the adapted bowel. 
Although the full amino acid sequence of enteroglucagon is known (71,129) 
there are considerable species differences, and only a small amount of 
porcine enteroglucagon, (glicentin) has thus far been produced. Thus, 
very little material has been available for direct infusional studies, 
and work related to enterocyte turnover has, as yet, not been done. For 
these reasons, the experimental approach in these studies, was to relate 
the hormonal changes in the various models, to the crypt cell production 
rate, which accurately reflects the proliferative status (213). The 
majority of the studies were undertaken in male Wistar rats, while the 
work relating to the mode of enteroglucagon release after intestinal 
surgery, was done in man. 
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C H A P T E R 3 
E V I D E N C E F O R A H U M O R A L M E C H A N I S M I N 
I N T E S T I N A L AD APT AT ION, A N D T H E P O S S I B L E 
R E L A T I O N S H I P T 0 E N T E R O G L U C A G O N A N D 
G A S T R I N 
INTRODUCTION 
The role of luminal nutrition and PBS in promoting intestinal adaptation 
in the shortened bowel, is well established. Humoral factors may well 
play a role. It is, however, not yet established which humoral factors 
are involved, and what their possible relationship is to the luminal 
factors mentioned. Furthermore, it is not yet known whether humoral 
agents are released from the residual bowel, and if so, whether this is 
in response to luminal nutrition and PBS. 
The purpose and aims of the following study, was firstly to determine if 
a humoral agent is involved after small intestinal resection, and to 
investigate whether enteroglucagon and gastrin qualify for the role of 
'enterotrophin' to the small bowel. It was also intended to determine 
the relationship of the release of these peptides to intraluminal factors. 
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A 
Fig 3.1: Thiry-Vella fistula, comprising 75% of 
proximal small bowel (AB). 
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MATERIAL AND METHODS 
Sixteen male Wistar rats, weighing 220-250g at the time of surgery, were 
used for the study. On the day of surgery, the rats were anaesthetised 
with intramuscular Hypnorm (fentanyl and fluanisone) (Janssen Pharmaceut-
ica. Inc. New Brunswick, NJ), and intraperitoneal Valium (diazepam, Roche 
Laboratories, Nutley, NJ). A midline abdominal incision was made, and 
each animal had a 75% proximal small bowel exclusion performed, measured 
from the ligament of Treitz. The excluded bowel was left attached to its 
mesenteric neurovascular supply, and the two open ends of this excluded 
segment were brought out via puncture wounds on the anterior abdominal 
wall (Fig 3.1) creating a Thiry-Vella mucus fistula (TVF) (214). 
Continuity of the residual bowel, was restored with an end-to-end 
anastomosis, using a single layer ofcontinuous6/0 black silk. Care was 
taken not to stenose the lumen at the anastomosis, and this was tested 
for by ensuring that bowel content could pass across the anastomosis. 
The Thiry-Vella fistula thus created, is excluded from luminal nutrition 
and PBS. 
In eight rats, a length of fine vinyl tubing (Bradley miniature catheter 
set, Portex Ltd., Hythe, Kent, UK) was inserted into the superior vena 
cava via the internal jugular vein. The tube was brought out at the 
back of the neck, via a subcutaneous tunnel, and secured with a suture, 
for intravenous feeding purposes (215)" 
The first group of rats, without the catheter, were allowed food ad 
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libitum. This was in the form of Pelleted Rat Diet (Labsure Animal 
Foods, Poole, Dorset, UK). The diet, containing 2568 Kcal/kg metabol-
izable energy consists of 19.7% crude protein, 53.5% carbohydrate, 
5.3% crude fibre, 2.7% crude oils, 0.6% calcium, 0.7% phosphorus, 
1% NaCl, trace elements and added vitamins. The group with the venous 
cannulae were nourished exclusively by total parenteral nutrition (TPN) 
(215). The end of the catheter was attached to a perfusion pump. The 
catheter itself was protected by a wire coil spiral which was attached 
to a harness fitted around the chest of the animal. The feeding regime 
consisted of a mixture of 35% dextrose solution and synthamine amino acid 
solution with added electrolytes, trace elements and vitamins. (Baxter 
Division, Travenol Laboratories Ltd., Thetford, Norfolk, UK). An amount 
of 40ml/day for the TPN fluid was administered to each animal. 
A further 16 animals had a laparotomy and transection just distal to the 
ligament of Treitz. The transected bowel was then reanastomosed with a 
single layer of 6/0 black silk, and these animals acted as controls. 
Eight animals of this transected control group were allowed food ad 
libitum, while the other eight in this group had Vinyl tubing inserted 
at the time of surgery, and were nourished exclusively by TPN as des-
cribed above. A record was kept of the amount of food consumed by the 
orally fed rats, and animals were weighed at the time of surgery and 
before they were killed. 
All rats were killed on the twelfth post operative day, after an over-
night fast or discontinuation of TPN, depending on the group. At 9.30 
hrs all animals were given vincristine (Oncovin, Eli Lilly & Co. Ltd., 
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Basingstoke, UK) which was administered by intraperitoneal injection in 
a dose of lmg/kg body weight, for stathmokinetic studies (see below). 
Animals were then killed at 20 minute intervals. Blood was taken by 
direct cardiac puncture for plasma gastrin and enteroglucagon radio-
immunoassay. The blood was placed into heparinised tubes, containing 
0.2ml of Aprotinin (trasylol 20,000 KIU/ml), centrifuged immediately, 
and the plasma stored at -20°C, to await radioimmunoassay. 
PLASMA ENTEROGLUCAGON ASSAY (216): 
Two assays were performed, one for total glucagon-like immunoreactivity, 
using an N-terminally reacting antiserum, R-59, which reacts fully with 
pure porcine enteroglucagon (glicentin) and one for pancreatic glucagon, 
using a relatively specific C-terminally reacting antiserum RCS-5. 
Plasma enteroglucagon levels were then obtained by subtracting the small 
concentrationof pancreatic glucagon from total glucagon. Changes of 
lOpmol/litre plasma, could be detected with 95% confidence. The cross-
reacting antibodies were raised in rabbits to porcine pancreatic glucagon. 
The antibody-bound and 'free' peptide was separated using dextran-coated 
charcoal. 
PLASMA GASTRIN ASSAY (217): 
Plasma immunoreactive gastrin was measured using a C terminal antisera 
to G-17. This fully detected G-34, but showed less than 5% cross-
reaction to cholecystokinin. Changes of 2pmol/litre plasma could be 
detected with 95% confidence. 
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CRYPT CELL PRODUCTION RATE (CCPR) (213,218): 
The CCPR was measured using the stathmokinetic method, involving a meta-
phase arrest technique (219,220,221) with vincristine (219,222). At 9.30 
hrs on the twelfth post-operative day, each rat was given vincristine 
(Oncovin, Eli Lilly & Co. Ltd., Basingstoke, UK), 1 mg/kg body weight, 
by intraperitoneal injection. The first rat in each group was killed 
30 mins after vincrisine injection and the remaining animals were killed 
at 20 minute intervals thereafter, for 3 hours. Five cm, segments of 
bowel were taken in each animal, from the terminal ileum, and mid point 
of the Thiry-Vella fistula. These tissues were fixed in Carney's fluid 
for 4 hours, and then transferred to 75% ethanol for storage, pending 
microdissection. On the day of examination, the tissues were rehydrated 
and hydrolysed for 6 minutes in N HCl at 60°C, and then stained with 
Feulgen reagent for 1 hour. The mucosa was stripped from the muscle 
coat, and the crypts were individually dissected out, using a dissecting 
microscope. The number of arrested metaphases in each crypt was counted, 
and the mean metaphase counts of ten crypts was taken as the reading for 
each individual rat. This was then plotted against time after vincristine 
injection, and the CCPR for the whole group is represented by the slope 
of the line that best fitted the eight individual points (Fig 3.2), 
produced by linear regression and least-squares curve fitting (222,223). 
This method also produces standard errors of the mean. 
STATISTICAL METHODS: 
The Student's t-test for unpaired data was used for the group analysis 
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Fig 3.3: Mean and SEM values of plasma enteroglucagon and 
gastrin in the Thiry-Vella fistula (TVF) animals, 
shown in the upper panel. The lower panel shows 
the crypt cell production rate (CCPR) per hour, in 
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There was no significant difference in the daily caloric intake of the 
different groups, In the TPN rats, 40ml of the feeding fluid per day, 
provided 27.0Kcal. Measurement of food taken by rats on oral nutrition, 
revealed a caloric intake of 26.8!4.lKcal/day in Thiry-Vella fistula 
animals, and 27.7!4.5Kcal/day in transection animals. 
PLASMA ENTEROGLUCAGON AND GASTRIN: 
In rats with the Thiry-Vella fistula (TVF) enteroglucagon was significant-
ly greater in orally fed rats (566!59pmol/l), compared with TPN animals 
(120!42pmol/l) (P(0.01) (Fig 3.3). Plasma gastrin, however, did not 
+ + differ in the two groups (56-5.8 and 56.4-15.2pmol/l respectively). 
+ In transected orally fed rats, plasma enteroglucagon (99.1-9.6pmol/l) 
was greater than in transected TPN rats (63.1!9.4) (P(0.02) (Fig 3.4). 
Similiarly, gastrin in orally fed transected animals (38.1!4.4pmol/l) was 
greater than in transected TPN rats (25!3.2pmol/l) (P<0.05) (Fig 3.4). 
Thiry-Vella fistula rats had greater concentrations of hormones, both 
enteroglucagon and gastrin, than transected rats in both groups. Thus 
TVF orally fed rats had greater enteroglucagon and gastrin levels than 
transected orally fed rats (P(0.001 and P<:0.025 respectively}, and TVF 
rats on TPN had greater enteroglucagon and gastrin levels compared to 
transected TPN rats (P(0.001 and P<0.05 respectively). 
CRYPT CELL PRODUCTION RATE: 
In the terminal ileum in continuity in the Thiry-Vella group, the CCPR 
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per hour in orally fed rats (52!8) was ~reater than in the TPN group 
(18~5) (P<0.001) (Fi~ 3.3). In the midpoint of the excluded TVF, the 
+ CCPR per hour in orally fed rats was 28.3-2, and this was significantly 
greater than the CCPR per hour in the fistula in TPN animals (16!1.5) 
(P(0.01). The CCPR per hour in the terminal ileum of orally fed tran-
sected animals (16.8~0.9) was significantly greater than in transected 
TPN rats (12!0.4) (P<0.01) (Fig 3.4). Orally fed TVF rats had a greater 
CCPR per hour in the terminal ileum than orally fed transected rats 
(P(0.001). In the TPN rats, although the terminal ilea! CCPR per hour 
in TVF animals was greater than in the transected rats, this did not 
reach statistical significance. 
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DISCUSSION 
A number of radioimmunoassays for enteroglucagon have been reported 
(224,225,226). These are all broadly similiar, and rely on the use of 
antisera raised to pancreatic glucagon, which cross react with enteric 
glucagon-like immunoreactivity. A small number of antibodies cross 
react completely with enteric and pancreatic glucagon, and can thus be 
used for measurement of total glucaP,on-like immunoreactivity. These 
antibodies, such as R59, are directed towards the middle and N-terminal 
portion of the glucagon sequence. Other antisera, such as RCS5, show 
minimal cross reactivity with enterogluca~on, and are directed towards 
the C-terminal region of the glucagon molecule, and are thus 'specific' 
for pancreatic glucagon. Since circulating pancreatic glucagon levels 
are usually small, subtraction of this level from total glucagon will 
result in the level of enteroglucagon concentration. It has been found, 
that all the cross-reacting glucagon antisera give the same molar values 
for enteroglucagon and provide reproducible results when a glicentin 
standard is assayed (227). 
A multiplicity of methods for measuring the proliferative r&~e in the gut 
have been used (213), and these include: incorporation of tritiated 
thymidine (3 HTdR) into DNA, mitotic index, 3 HTdR labelling index, cell 
cycle time, growth fraction, birth rate measurement such as CCPR, cell 
migration rate, transit time, and rate of exfoliation of mucosal cells. 
The incorporation of 3 HTdR into tissues has been used as a measurement of 
DNA synthesis in the gut (228), although it is now recognised that it is 
not necessarily an accurate reflection of the DNA synthetic rate, or 
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indeed of the crypt cell production rate (229). 3 HTdR is only minim-
ally incorporated into the DNA of intact cells, there are many steps 
and pathways for the incorporation of 3 HTdR into DNA, and this may be 
modified by thymidine incorporation enzymes, changes in TdR pool size and 
3 HTdR transport through the cell membrane (230,231). Furthermore, by 
this method, the non-epithelial cell populations, especially the lymph-
oid cells, will be included (213). The proliferative indices, such as 
mitotic index and labelling index, are measured by autoradiography, and 
give the proportion of cells in DNA synthesis. Unlike 3 HTdR incorpor-
ation into DNA, these measurements are confined to the epithelial compon-
ent of the intestine. However, they only reflect the fraction of cells 
in mitosis and DNA synthesis, and changes in the duration of these phases 
can cause an increase in mitotic index or labelling index (232,233) giving 
rise to limitations of these methods. Furthermore, changes in crypt 
population will effect proliferative indices. Thus, large crypts may 
contain the same fraction of labelled or mitotic cells as smaller crypts, 
but the cell production rate will be higher because of an increase in 
crypt cell number. For these and other reasons, crypt cell production 
rate has been used as a measurement of proliferative rate in these 
experiments. It reflects the rate of production of new cells, and is 
measured by the metaphase arrest, or stathmokinetic method (219,220,221). 
In this method, the ability of drugs such as vincristine, is used to 
arrest cells in metaphase, and thus to measure the rate of entry of cells 
into mitosis. This rate of entry into mitosis, reflects the birth rate 
of new cells, since each mitosis results in the net production of one 
cell. This method has been found to be cost effective in terms of time 
expenditure on analysis and in terms of animals. The experiments take 
a short time (up to 3 hours). The method is independent of any other 
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parameter, and gives information on changes in both cell cycle time and 
growth fraction. This technique has been regarded as a method of choice 
(221,234). 
The finding in this study, of greater cellular proliferation (CCPR) in 
the terminal ileum of orally fed Thiry-Vella fistula rats compared to 
orally fed controls (jejunal transection), supports the findings of 
previous workers (1,21,24,25,26,27,28,29,34,35,41,43), that shortening 
the bowel, promotes adaptive hyperplasia in the residual intestine. 
These changes may well be promoted by luminal nutrition, and pancreatico-
biliary secretions. Here the distal shortened intestine comes into 
contact with greater volumes of luminal content, and food in which 
nutrients have not been absorbed higher up. This abnormally rich chyme 
has the effect of stimulating hyperplasia in the terminal ileum of the 
shortened bowel, and this view is supported by jejuno-ileal transposition 
experiments (36,44) in which the transposed ileum is placed more proxim-
ally in the gastro-intestinal tract and undergoes hyperplasia after coming 
into contact with a greater volume and richer chyme. Equally, pancreatico-
biliary secretions, which have been regarded as trophic agents (44,72, 
73,74) may well be implicated in the changes in CCPR in the terminal ileum, 
seen in the orally fed Thiry-Vella fistula rats. Furthermore, the reduced 
CCPR, signifying hypoplasia, in the terminal ileum of intravenously fed 
(TPN) animals, both TVF and transection groups, is in keeping with previous 
work (59,60,61,62), and once again supports the view of luminal nutrition 
as an important promotor of intestinal mucosal growth. Total parenteral 
nutrition is known to cause pancreatic atrophy in rats (59), and the 
findings in the TPN rats in this study, may equally be in part, due to 
reduced pancreatic secretions and bile. Unlike the orally fed rats, there 
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was no significant difference in CCPR in the terminal ileum, between 
Thiry-Vella fistula and jejunal transected animals having TPN, once 
again supporting the role of luminal nutrition in adaptive changes 
in orally fed animals. 
The changes taking place in cellular proliferation within the Thiry-
Vella fistula, must be totally independent of the direct effect of 
luminal nutrition and pancreatico-biliary secretions. Crypt cell 
production rate within this isolated fistula, was significantly greater 
in orally fed compared to TPN rats. In this respect, it is not 
possible to incriminate food and PBS as being responsible for these 
changes, and the changes in CCPR in the fistula can only be explained 
on the basis of a systemic trophic factor released in the case of the 
orally fed TVF animals. This finding is in keeping with the adaptive 
cn.anges seen in Thiry-Vella jejunal loops in lactating rats (91), and 
the biochemical and morphological adaptive changes in defunctioned 
segments of bowel, produced by partial resection of the bowel in 
continuity (57,88,89,90). Such studies all point to a systemic humoral 
'enterotrophin'. This being the case, the results of the present study, 
indicate that a systemic trophic factor is released from the bowel in 
the orally fed TVF rats, which then passes via the circulation to the 
isolated fistula to produce the mucosal hyperplasia. Such a systemic 
factor is either not released or only minimally released in the case 
of the TPN Thiry-Vella fistula rats; hence the hypoplasia seen in the 
fistula in this group. As the only difference in the two groups was the 
mode of administration of nutrition, luminal nutrition in the orally fed 
rats is very likely to be responsible for releasing this humoral factor. 
PBS were probably reduced in the TPN rats (59), and these secretions may 
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also contribute to the release of a humoral factor. Furthermore, the 
data suggest that the direct effect of trophic agents on intestinal 
mucosa is stronger than the transmitted effect, as the hyperplastic 
changes in the fistula were less than the changes in the terminal 
ileum in continuity, in orally fed rats. This is in keeping with the 
findings in cross circulation parabiotic studies (93) where the domin-
ant partner had an intestinal resection and transection, while the 
responding partner had no abdominal operation. The resected and 
transected partners only showed rises in RNA and DNA, while both 
partners showed marked and similiar elevations ()60%) in total and 
specific radioactivity, implicating a transmissible factor, although 
the transmitted response was weaker than the direct response. 
The two possible trophic hormones investigated in this study, entero-
glucagon and gastrin, showed very different responses. In Thiry-Vella 
fistula animals, orally fed rats had significantly greater plasma entero-
glucagon levels than TPN animals, while plasma gastrin showed no change 
between the groups. After jejuna! transection, plasma enteroglucagon in 
orally fed rats was much greater than in TPN rats. Although orally fed 
transected rats had greater plasma gastrin levels than transected TPN 
rats, this difference was not marked (P<0.025). While gastrin may well 
have a regulating effect on growth of the oxyntic gland area of the 
stomach, the duodenum, colon and exocrine pancreas (103,111,112,113,122), 
the results in the Thiry-Vella fistula rats, supports the view (105,107, 
108,110), that gastrin has little, if any trophic influence in the mucosa 
of small bowel. 
In contrast, the changes in plasma enteroglucagon are in keeping with this 
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peptide being a strong candidate for a trophic role on small bowel 
mucosa. The markedly greater levels of enteroglucagon in orally fed 
compared with TPN rats in both Thiry-Vella fistula and transection 
groups, suggests that this peptide is released by food, and that in the 
shortened bowel, greater concentrations of richer chyme reaching the 
distally placed greatest concentration of EG cells (135), is the 
stimulus for the excessive secretion of enteroglucagon in this situation. 
The EG cells have microvilli protruding into the lumen, which act as 
sensors to changes in luminal content (71,129,136), and indeed, the 
major stimuli for the release of enteroglucagon has been shown to be 
carbohydrates and fats (137,138). In this study, the changes in plasma 
enteroglucagon and CCPR are in close agreement. While the changes in 
CCPR in the bowel in continuity may well be partly due to the direct 
stimulatory effect of food, the changes within the Thiry-Vella isolated 
fistula, must be independent of food and due to a systemic factor, and 
enteroglucagon, in this study, fulfils all the criteria for such a role. 
Assuming that the mechanisms of the adaptive response are uniform, it 
seems likely that food, and possible PBS, are the local stimuli for the 
release of a trophic humeral agent from the bowel in continuity, which 
may then act locally in a paracrine fashion, and systemically as a con-
ventional hormone. This would explain the more marked rise in CCPR in 
the bowel in continuity, with a lesser effect on the fistula. The data 
in this study relating to enteroglucagon, while not producing a cause-
and-effect situation, suggests that this peptide may well be trophic to 
small bowel mucosa, and is in agreement with the suggestion that this 




The results of this study, indicate that the mechanisms of the adaptive 
hyperplastic response in the shortened small intestine are multifactor-
ial, with luminal nutrition being important. However, systemic trophic 
agents are almost certainly involved in this process. In this respect, 
although gastrin is unlikely to exert a trophic effect on small bowel, 
enteroglucagon should be regarded as a likely candidate. 
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C H A P T E R 4 
T H E I N F L U E N C E 0 F T H E A M O U N T O F I N G E S T E D ------------------------
N U T R I E N T S 0 N C E L L U L A R P R O L I F E R A T I O N 
T H E B O W E L A F T E R I N T E S T I N A L RESECTION, 
A N D I T S E F F E C T 0 N P O S S I B L E 'ENTER O -
~RO PH INS', E N T E R O G L U C A G O N A N D GAST RI N. 
INTRODUCTION 
The mechanisms of intestinal adaptation are multifactorial, with luminal 
nutrition playing an important role. The previous study (Chapter 3) 
confirmed that humoral agents almost certainly participate in this 
process, and in this respect, enteroglucagon appears to be a likely 
candidate. The present study was undertaken, to investigate the inter-
relationship of luminal nutrition, humoral agents and cellular prol-
iferation more closely. In particular, it was aimed to determine the 
effect of the amount of ingested food on cellular proliferation, in 
control states, and after small intestinal resection, and the influence 





Fig 4.1: Jejunal transection (a), and 75% proximal 
small bowel resection (b). 
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MATERIAL AND METHODS 
Fifty-six Wistar rats, weighing 220-250g at the time of surgery, were 
used for this study. Intramuscular Hypnorm (fentanyl and fluanisone -
Janssen Pharmceutica Inc. New Brunswick, NJ) and intraperitoneal Valium 
(diazepam, Roche Laboratories, Nutley, NJ)were used as anaesthetic. Ei?ht 
animals had a sham laparotomy, with handling of the bowel only. The 
remaining 48 rats, were allocated to one of two operation groups. 
Twenty-four animals had a transection of the jejunum just distal to the 
ligament of Treitz, with reanastomosis. The remaining 24 rats had a 75% 
proximal small bowel resection, as measured from the ligament of Treitz, 
with jejuno-ileal end-to-end anastomosis to restore continuity (Fig 4.1). 
All anastomoses were fashioned with a single layer of continuous 6/0 
black silk, and care was taken that there was no stenosis at the site. 
This was checked for by confirming that bowel content could be 'milked' 
across the anastomosis. The 48 rats, having either transection or 
resection, were further subdivided into 3 groups, depending on their 
nutritional intake, as follows: 
a) Eight transected rats and 8 resected rats were allowed food ad 
libitum. This was in the form of Pelleted Rat Diet (Labsure 
Animal Foods, Poole, Dorset). 
b) Eight transected rats and 8 resected rats were allowed food ad 
libitum, but from the 5th post operative day, were kept under hypo-
thermic conditions at 6°C, to encourage hyperphagia (235). 
c) Eight rats having transection and 8 rats having resection, had 
fine vinyl catheters (Bradley miniature catheter set, Portex Ltd., 
Hythe, Kent) inserted into the superior vena cava, via the int. 
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jugular, and brought out at the back of the neck, via a sub-
cutaneous tunnel (215). This group was nourished exclusively 
intravenously (TPN) as described in Chapter 3. The feeding regime 
consisted of a mixture of Synthamin amino acid solution with added 
electrolytes and trace elements and vitamins (Baxter Division, 
Travenol Laboratories Ltd., Thetford, Norfolk) and a 35% dextrose 
solution. The amount of TPN fluid thus administered, was 40ml/day. 
All animals were weighed at the beginning and the end of the experiment 
the daily intake of food was calculated by subtracting the food weight 
at the end of the experiment from the starting amount. All animals were 
killed on the 12th post operative day. Blood was taken by direct 
cardiac punctureforgastrin and enteroglucagon assay, and was placed in 
heparinised tubes containing Trasylol, centrifuged immediately, and the 
plasma was stored at -20°C pending assay. Segments of intestine, 5cms in 
length were taken from the duodenum, above and below the anastomosis, 
the terminal ileum and the colon, for cell kinetic studies. 
RADIOIMMUNOASSAY: 
Assays for enteroglucagon (216) and gastrin (217), were performed as 
described in Chapter 3. 
CRYPT CELL PRODUCTION RATE (CCPR) (213,218): 




WEIGHT LOSS AFTER THE DIFFERENT 
PROCEDURES, AND DAILY FOOD INTAKE. 
Procedure 
Sham op. 






(n.f. = Normal feeding; 
h = hyperphagia) 










iv -- intravenous feeding; 
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TRANSECT ION RESECTION 
Fig 4.2: Mean crypt cell production rates per hour (CCPR/h) 
in the intestine, after jejunal transection and 
75% proximal small bowel resection. 
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RESULTS 
WEIGHT CHANGES AND NUTRITIONAL INTAKE: 
Weight changes and nutritional intake for the groups, are shown in 
Table 4.1. 
CRYPT CELL PRODUCTION RATE (CCPR): 
The general distribution of CCPR in the rats taking food ad libitum, is 
shown in Fig 4.2 for transected and resected rats. The figures were 
highest just distal to the anastomosis and then tapered off distally. 
However increased cell production occurred above the anastomosis and in 
the duodenum, in resected rats. In all positions, resection produced 
higher cell productionratescompared to transection (P<0.001). Similiar 
distribution of CCPR was found in TPN and hyperphagic rats, but for 
simplicity only the results in the terminal ileum will be given. 
CCPR IN TERMINAL ILEUM, AND PLASMA ENTEROGLUCAGON AND GASTRIN: 
a) Normal feeding (ad lib): 
Fig 4.3 shows CCPR in the terminal ileum and plasma enteroglucagon 
and gastrin in sham operated, transected and resected animals. There 
was no significant difference between these results in the sham and 
transected groups. However, CCPR increased from 16.8~0.9 cells per 
crypt per hour in transected to 49.2!4.9 in resected rats (P(0.001). 
Enteroglucagon increased from 99.1!96pmol/l in transected to 
+ 
667.0-70.lpmol/l in resected animals (P(0.001). Gastrin increased 
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Fig 4.3: Changes in crypt cell production
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Fig 4.4: Crypt cell production rate per h
our (CCPR/h) 
in the terminal ileum and plasma enterogluc
agon 
and gastrin after jejunal transection and 
75% 
small bowel resection, in rats on intraveno
us 
feeding. 
- 76 - D ((.l'R 
D tnltroqluO<,On 












0.. 30 u 
800 3: 




10 . 200 
:::::::: 
transection resrction 
Fig 4.5: Crypt cell production rate per hour (CCPR/h), 
and plasma enteroglucagon and gastrin, after 
ileal transection and 75% proxtmal small bowel 
resection, in animals with hyperphagia, induced 
by hypothermia. 
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Fig 4.6: Crypt cell production rate per hour (CCPR/h) and 
plasma enteroglucagon and gastrin, after ileal 
transection and 75% proximal small bowel resection 





Intravenously fed rats (Fig 4.4): 
+ 
The CCPR in the ileum increased from 12-0.4 cells per crypt per 
+ 
hour in transected animals to 21.3-1.3 cells per crypt per hour in 
resected animals (P<0.001). Enteroglucagon incresed from 63.1:9.4 
pmol/1 in transected rats to 184.4:15.Spmol/l in resected animals 
(P<0.01), although there was no significant change in plasma gastrin. 
Hypothermic hyperphagic rats (Fig 4.5): 
The CCPR in the ileum increased from 27.9:1.2 cells per crypt per 
hour in transected, to 51.6:2.5 in the resected rats (P<0.001). 
There was an increase of enteroglucagon from 311.9!22.2pmol/l in 
transected rats, to 1152:236.5pmol/l in the resected group (P<0.005). 
Gastrin, however, did not change in the two groups. 
d) Group as a whole: 
Fig 4.6 shows the CCPR and plasma enteroglucagon and gastrin, for 
transected and resected rats, undergoing the different forms of 
nutritional intake. 
i) CCPR: 
Fig 4.7 illustrates a cross sectional view of the terminal 
ileum in transected animals and animals having 75% proximal 
small bowel resection on normal feeding, IV feeding and hyper-
phagia induced by hypothermia. In transected rats the CCPR 
+ + 
on normal feeding (16.8-0.9) fell to 12-0.4 after TPN(P<0.001) 
but rose to 27.9:1.2 with hyperphagia (P(0.001). In resected 
rats the CCPR on normal feeding (49.2:4.9), fell to 21.3:1.3 
(P<0.001) in TPN rats. However, although the CCPR in hyper-
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Fig 4.7: Cross section of ileum in animals with (from left) intestinal 
resection and IV feeding, intestinal resection and hypothermic 
hyperphagia, intestinal resection on normal feeding, and 
jejunal transection and normal feeding. 
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phagic resected rats did increase to 51.6!2.5, this was 
not statistically different from resected rats on normal 
feeding. 
ii) Plasma enteroglucagon and gastrin: 
In transected rats, the plasma levels of enteroglucagon 
and gastrin in normally fed rats, was significantly higher 
than levels in TPN rats (P<0.02 and(0.001 respectively) while 
these levels rose significantly in hyperphagic transected 
rats (P<0.001). In resected rats, the levels of enteroglucagon 
and gastrin in animals feeding normally, fell significantly 
with TPN (P<0.001 and(0.02 respectively). In hyperphagic 
resected animals, although enteroglucagon rose from 667!70.1 
pmol/1 in resected rats eating normally, to 1152!236.5pmol/l 
this failed to reach statistical significance. Gastrin in 
this situation decreased slightly, although once again, this 
was not significant. 
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DISCUSSION 
The marked adaptive hyperplasia seen in the terminal ileum after 
extensive proximal small bowel resection in this study, is in agree-
ment with previous studies showing intestinal adaptation in the 
residual shortened intestine (1,21,24,25,26,27,28,29,34,35,41,43). 
There seems very little doubt, that luminal nutrition is important in 
promoting these adaptive changes, and this is confirmed by the data in 
this study, which furthermore, indicates that the amount of food present-
ed to the residual bowel, is important. This is clearly seen in tran-
sected rats, where a CCPR of 12 in the TPN group indicates hypoplasia, 
this increasing to 17 in normally fed rats, and ultimately to 28 cells 
per crypt per hour in the hyperphagic group, all these changes being 
highly significant (P(0.001). The same trend is shown in the resected 
rats, whereTPN animals had a CCPR of 21, which increased to 49 in normally 
fed animals (P(0.001). There was a further increase to 52 cells per 
crypt per hour in hyperphagic rats, although this did not show a statist-
ically significant change from the normally fed group, and it may well be 
that a limit is reached, above which cell production rate is not able to 
increase. These findings confirm those of others, that the hyperphagia 
in pregnant and diabetic rats (47,48,49,50,51,52), results in villus hyper-
plasia in small bowel, although clearly, other endocrine factors may be 
operative in these models, and that TPN leads to hypoplastic changes (59, 
60). Indeed, it has been shown that jejunal and ileal mucosa undergoes 
hypoplasia during TPN, as early as the third day(60). 
The highly significant increases in CCPR from transected to resected 
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animals in the normally fed and hyperphagic groups, can certainly be 
explained on the bases of luminal nutrition, by the fact that after 
resection, the residual ileum comes into contact with a larger volume 
of food and unabsorbed nutrients, to which it is normally unaccustomed, 
which then results in the hyperplastic changes. This view is supported 
by ileojejunal transposition experiments (36,44), where the ileum is 
transported to a proximal position, and undergoes hyperplasia, although 
the total length of the gut is unaltered. Luminal nutrition, can how-
ever, not be held responsible for the significant increase in CCPR in 
resected compared with transected rats having TPN. While it is possible 
thatpancreatico-biliary secretions, which have been regarded as having a 
trophic influence on small bowel (44,72,73,74), may be responsible for 
these changes, inview of the absent food in the gut, it seems likely 
that reduced amounts of PBS would be produced in these animals. Indeed, 
pancreatic atrophy has been observed in TPN rats (59). However, pooled 
pre-harvested pancreatic juice perfused into isolated intestinal loops, 
has produced modest adaptation (72,80). 
An alternative explanation for the changes seen in TPN rats, would be a 
humeral factor. The two hormones investigated in this study, showed very 
different patterns of release. Although gastrin levels were greater in 
resected compared with transected normally fed rats, in keeping with the 
hypergastrinaemia noted after major small bowel resections (100,101,102), 
there was no such change in the TPN and hyperphagic groups of animals, 
despite very marked alterations in CCPR. It is unlikely, therefore, that 
gastrin has played a part in promoting hyperplasia in these models. The 
changes in plasma enteroglucagon, however, correlate closely to the changes 
in CCPR in all the different groups (Fig 4.6). In transected rats, there 
was a stepwise increase in plasma enteroglucagon, related to the amount 
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of luminal nutrition taken, and this corresponded to increases in CCPR. 
In resected rats, there was an increase from TPN to normally fed rats, 
similiar to changes in CCPR. Although enteroglucagon increased from 667 
in normally fed resected rats, to 1152 in resected hyperphagic animals, 
as with CCPR in these modes, this did not reach statistical significance, 
and there may similiarly be a limiting level above which it is not 
possible for the EG cells to produce more peptide, no matter how great 
the stimulus. 
Food is the major stimulus for the production of enteroglucagon, and in 
this respect, carbohydrates and long chain fatty acids are important 
(137,138). The EG cells are of the 'open' variety, with microvilli, 
which act as 'sensors' to changes in luminal content, protruding into 
the lumen (71,129,136), and these EG cells have a distal distribution, 
with the maximum concentration found in the distal ileum, with a lesser 
but still significant concentration found in the colon (135). Further-
more, although hypertonic glucose solutions provide a strong stimulus to 
enteroglucagon release, it appears to be the amount of glucose presented 
to the mucosa, rather than the tonicity which determines the strength 
of the stimulus (71). These facts explain the changes in plasma entero-
glucagon seen after resection in orally fed animals in this study. After 
75% proximal small bowel resection because of proximal malabsorption, 
the EG rich terminal ileum is effectively brought into contact with a 
greater volume of luminal nutrition, and furthermore, this contains 
nutrients which should have been absorbed more proximally in the gut, 
thus providing the EG cells with a richer mixture of chyme. The EG 
cells are thus stimulated to hypersecrete, and under these circumstances, 
a reduction in the number of secretory granules in the EG cell, denot-
ing hyperfunction, has been observed (16~). Clearly, hypersecretion 
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of enteroglucagon can occur by increasing the volume of food taken, with-
out resection, as seen in the transected rats in this study. 
As with CCPR, the increase in enteroglucagon in resected compared to 
transected TPN rats, must be independent of food. Other causes for the 
change in enteroglucagon, must be operative. It is possible that PBS 
may stimulate enteroglucagon, although this is speculative. If this is 
the cause, the amounts of PBS in TPN are probably small because of pan-
creatic atrophy (59). Whatever the other factors responsible for entero-
glucagon release in TPN rats, the levels of this peptide correspond to 
changes in CCPR in these models. 
- 84 -
CONCLUSION: 
The findings in this study, confirm that intense adaptive hyperplasia is 
produced in the residual small bowel, after major proximal resections. 
The mechanisms of this adaptation are multifactorial, as although lum-
inal nutrition is clearly important, it cannot explain the changes seen 
in TPN rats, and humoral factors may well be operative. Because of the 
close correlation to changes in CCPR, enteroglucagon seems a more likely 
candidate than gastrin in this respect. Because of the situation of the 
EG cells, and the stimulatory mechanisms, it seems likely that luminal 
nutrition may produce its effect on mucosal enterocyte turnover, through 
enteroglucagon, although there appears to be other mechanisms of entero-
glucagon release and thus changes in cell proliferation. Furthermore, 
the amount of luminal nutrition is important in regulating enteroglucagon 
release, and thus cell turnover, although there is a limiting level, 
above which peptide secretion and cell production rate, cannot increase, 
despite increase in luminal nutrition. 
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C H A P T E R 5 
T H E I N F L U E N C E 0 F P A N C R E A T I C O - B I L I A R Y 
S E C R E T I O N S 0 N C E L L U L A R P R O L I F E R A T I O N 
I N S M A L L BOWEL, A N D T H E I R P O S S I B L E 
R E L A T I O N S H I P T 0 H U M O R A L A G E N T S 
INTRODUCTION 
The recognition that the intestinal villi in the duodenum are twice the 
size of the villi in the ileum, the so called 'proximodistal gradient' 
of villus size (44,72,236) prompted the view, that pancreatico-biliary 
secretions (PBS) may be an important factor in promoting mucosa! growth. 
This view has been supported by finding of enhanced hyperplasia distal 
to the reimplanted duodenal ampullary region (44,72,73). In order to 
investigate this further, and to determine the relationship of PBS to 




Fig 5.1: Pancreatico-biliary diversion, (a) alone, 
and (b) with 75% proximal small bowel 
resection. 
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MATERIAL AND METHODS 
Thirty-two male Wistar rats, weighing 200-250g at the time of surgery, 
were used. Intramuscular Hypnorm and intraperitoneal Valium were used 
for anaesthetic. Eight rats had a jejunal transection below the ligament 
of Treitz, with end-to-end anastomosis, while a further 8 animals had a 
75% proximal small bowel resection, with an end-to-end jejuno-ileal 
anastomosis to restore continuity (Fig 4.1). The remaining 16 rats had 
a few ems of duodenum, containing the ampulla of Vater, excised. The 
proximal part of this segment was closed with a single layer of sutures, 
while the distal end was reanastomosed, end-to-sid~ to the mid-transverse 
colon. Eight rats in this group of pancreatico-biliary diversion (PBS), 
had an end-to-end duodena-jejuna! anastomosis to restore continuity, 
at the region of the ligament of Treitz. The remaining 8 rats in this 
group, in addition to the pancreatico-biliary diversion, had a 75% 
proximal small bowel resection, with a duodeno-ileal anastomosis to 
restore continuity (Fig 5.1). All anastomoses were performed with a 
continuous single layer of 6/0 black silk. All rats were allowed water 
and food ad libitum. Animals were weighed at the commencement of the 
experiment and at the time of killing, which was on the 12th post op-
erative day. The amount of food consumed was calculated by measurements 
at the beginning and the conclusion of the experiment. On the 12th post-
operative day, after an overnight fast, animals were killed by ether 
anaesthesia. Blood was taken by direct cardiac puncture and placed in 
heparinised tubes, containing Trasylol. The blood was immediately centri-
fuged and the serum was stored at -20°C to await assay. Five cm segments 
of bowel were taken from the duodenum, immediately below the anastomosis, 
the terminal ileum, and sigmoid colon for cell kinetic studies. 
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RADIOIMMUNOASSAY: 
Assay of enteroglucagon (216) and gastrin (217) were performed as 
described in Chapter 3. 
CRYPT CELL PRODUCTION RATE (CCPR) (213,218): 
This was performed, to assess cellular proliferation, as described in 
Chapter 3. 
STATISTICS: 
The students t-test for unpaired data was used for the group analysis 
and results are given as mean and standard error of the mean. 
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TABLE 5.1 
WEIGHT LOSS AFTER THE DIFFERENT 
PROCEDURES, AND DAILY FOOD INTAKE 
Procedure Weight loss 
(g) 
Jejunal transection 14.2::!:9.76 
75% small bowel resection 18.75::!:5.8 
Jejunal transection + PBD 46.87::!:7.04 















jl)j E .e .. ,. .. 






T 1111sec lion Resection 
Fig 5.2: Plasma enteroglucagon and gastrin levels, 
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NUTRITIONAL INTAKE AND WEIGHT CHANGES (Table 5.1): 
All animals lost weight post-operatively. Although this was signif-
icantly more in the group having PBD, despite similiar intake of food 
in the groups. The rats having PBD, had marked diarrhoea, and looked 
unwell. 
CRYPT CELL PRODUCTION RATE (Fig 5.2 and Table 5.2): 
In the terminal ileum of rats not having PBD, the CCPR in transected 
+ rats was 16.8-0.9 cells per crypt per hour, and this increased to 
49.2:4.9 after 75% proximal small bowel resection {P(0.001), After PBD 
alone, the CCPR in the terminal ileum was 12:0.6 cells per crypt per 
hour, and this increased to 18.8:o.9 in rats having PBD plus 75% proximal 
resection {P(0.001). When comparing rats having PBD alone with those 
having jejunal transection, the CCPR in the PBD group was significantly 
lower {P(0,001). Similiarly, the PBD rats with 75% resection, had a 
significantly lower CCPR than those having resection alone {P(0.001). 
PLASMA ENTEROGLUCAGON AND GASTRIN {Fig 5.2 and Table 5.3): 
In rats not having PBD, the plasma enteroglucagon level after jejunal 
+ + 
transection was 99.1-9.6pmol/l and this increased to 667.0-70.lpmol/l 
after 75% proximal resection (P<0,001). Plasma gastrin increased from 
38,l:4.3pmol/l in transected, to 81.9:13.3pmol/l in resected rats (p<0.005). 
Rats having PBD alone, had a plasma enteroglucagon level of 55.7:7.4pmol/l, 
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and this increased to 400!38.4pmol/l in rats having PBD plus 75% prox-
imal resection {P(0.001). Plasma gastrin in the PBD group alone 
(72.s!10.8pmol/l) did, however, not differ from the level in rats 
having PBD plus resection (55.7!7.4pmol/l). 
When comparing rats not having 75% proximal resection, plasma entero-
glucagon was significantly lower after PBD {P(0.005), as was plasma 
gastrin (P<0.01), compared with jejunal transection. Similiarly, 
plasma enteroglucagon was significantly higher after 75% resection 
compared with resection plus PBD (P(0.001), while gastrin did not show 
any significant change. 
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DISCUSSION 
The proximodistal gradient of villus size, has prompted workers in 
the field to suggest that intestinal secretions may be important in 
producing this size gradient, and pancreatico-biliary secretions have 
been regarded as being important in this respect (44,72,236). Indeed, 
diverting the ampullary region of the duodenum into the mid-small 
bowel (73) and into self emptying ileal loops (44,72), has produced 
distal hyperplasia, supporting the view that PBS may be trophic to 
small intestinal mucosa. Furthermore, perfusion of pre-harvested 
pancreatic juice into isolated intestinal loops, produced a modest 
degree of adaptation in these loops (72,80). 
The cell kinetic data in this study, are in keeping with the view 
that PBS may well be trophic to small intestine. A significantly 
lower CCPR in the terminal ileum, was found in rats having their PBS 
diverted to the colon, compared with those not having this procedure. 
This result when comparing the PBD rats with non-PBD animals, is al-
most certainly due to the presence or lack of PBS on the terminal 
ileum. Groups of rats had similiar nutritional intake, and food can 
thus not be incriminated in these changes, when comparing these 2 
broad groups (pancreatico-biliary diversion and non diversion). The 
marked loss of weight in the diverted group, can be accounted for by 
the marked diarrhoea and malabsorption. Luminal nutrition, on the other 
hand, was probably responsible for the increased CCPR in the terminal 
ileum of rats having PBD plus 75% proximal resection, compared with the 
groups having PBD alone. 
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The two hormones studied, gastrin and enteroglucagon, behave differently 
in this study. While there was an increase of gastrin in 75% resected rats 
compared with transected animals (?(0.005h the changes in plasma gastrin in 
the PBD rats and rats with PBD plus resection, were not significant, and 
gastrin can thus not be held responsible for the changes in CCPR in these 
models. Enteroglucagon, on the other hand, showed significant (P(0.001) 
changes in the four different groups, and these changes in enteroglucagon, 
corresponded closely to the changes in CCPR in these models. When comparing 
rats having jejunal transection and PBD alone, as the food intake was sim-
iliar, PBS must be regarded as being responsbile for the significant differ-
ences in plasma enteroglucagon and CCPR in these two groups. This must also 
be the case in rats having 75% proximal resection and those with PBD plus 
resection. Although pre-harvested pancreatic juice has a direct stimulatory 
effect on isolated segments of intestine (72,80), the direct effect of PBS 
on enteroglucagon release has as yet not been investigated. However, the 
data in this study suggests, that besides carbohydrates and fats (137,138), 
PBS may be a stimulatory factor for enteroglucagon release. In support of 
this hypothesis, is the work done by Miazza et al (81). A different 
type of pancreatico-diversion to the one in this study, was performed 
in rats. Here the proximal 50cm of small bowel was transposed to lie 
between the stomach and duodenum, thus depriving the jejunum of PBS. 
Animals were nourished either by TPN or orally, and PBD was compared with 
control animals having no PBD, but nourished either orally or by TPN. 
The ileum in the PBD animals, lying immediately downstream from the 
duodenal ampullary region, underwent adaptive changes, supporting the 
view that PBS are trophic to small bowel. Surprisingly, however, the 
jejunum in the PBD animals, now deprived of PBS, underwent hyperplasia 
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with increases in villus height, mucosal mass and absorptive capacity. 
This finding, at first sight, would be contrary to the theory of 
PBS being trophic to small bowel, with deprivation of the jejunum of 
PBS, this segment of bowel was expected to undergo hypoplasia. How-
ever, after measuring the plasma for enteroglucagon, it was found that 
animals undergoing PBD, had significantly raised levels of this peptide 
compared with controls (84). As there was no shortening of the gut in 
this model, it may well be, that PBS coming into contact with the 
enteroglucagon rich ileum, was the stimulatory factor in the PBD 
animals, and this peptide may well be responsible for the hyperplasic 
changes found in the jejunum in this model. 
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CONCLUSION 
The data in this study, support the view that PBS are trophic to 
small bowel. Unlike gastrin, plasma enteroglucagon changes correlated 
well with changes in cell turnover, and this peptide may well be , 
important in the adaptive response seen in these models. The results 
also suggest, that PBS may stimulate the release of enteroglucagon, 
and that trophic effect of PBS may be exerted via the release of this 
peptide. 
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C H A P T E R 6 
T H E I N F L U E N C E O F J E J U N O - I L E A L B Y P A S S 
A N D RESECTION, 0 N INTESTINAL AD APT AT ION 
A N D P L A S M A C O N C E N T R A T I O N S 0 F E N T E R O -
G L U C A G O N A N D G A S T R I N 
INTRODUCTION 
As with proximal small bowel resection, the shortened segment of small 
bowel in continuity with the nutrient stream after proximal jejuno-ileal 
bypass operations in the experimental animal, undergoes compensatory 
hyperplasia and enhanced absorptive function (23,26,58,63,65). This has 
also been shown to be the case in man, where jejuno-ileal bypass procedures 
have been carried out in the management of morbid obesity (30,31,237,238, 
239). Besides hyperplasia of the enterocytes, goblet (mucous) cell 
hyperplasia has also been shown to occur as part of the adaptive response 
in jejuno-ileal bypass (240). This is perhaps not surprising, as the 
stem cells in the base of the crypts of Lie~rk~hn, are regarded as 
pluripotential, giving rise to columnar, goblet, endocrine and Paneth 
cells (13). 
The mechanisms by which this adaptation takes place, are probably similiar 
to intestinal resection. Thus the direct effect of luminal nutrition 
is probably important, and in support of this, is the fact that the 
bypassed jejunum, undergoes marked hypoplasia, has slower migration and 
epithelial cell turnover, with reduced mucosa! content of enzymes, protein 
and m1cleic acids (23,26,58,63,65). Furthermore, these structural and 
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functional changes in the defunctioned jejunum, are completely reversed 
by restoration of normal intestinal continuity (58,63). While this 
certainly supports the concept of luminal nutrition as a mechanism 
in the adaptive response after jejuno-ileal bypass, intestinal secret-
ions, such as bile and pancreatic juice, may similiarly account for 
these changes. 
However, as humeral mechanisms have been postulated to be important 
in intestinal adaptation (85,92,93,94,95,98), and hormonal changes 
have been shown to occur after jejuno-ileal bypass for morbid obesity 
(149), this study was undertaken to compare the adaptive changes after 
jejuno-ileal bypass with those taking place after an equivalent length 
of small bowel resection, and to determine the role of hormones in 
the mechanism of the adaptive response after bypass surgery. 
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(a) (b)" 
Fig 6.1: 75% proximal jejuno-ileal bypass (a), and 
75% proximal small bowel resection (b). 
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MATERIAL AND METHODS 
Twenty-four male Wistar rats were used, weighing 200-250gms at the 
time of surgery. Eight rats had a 75% proximal small bowel resection, 
measured from the ligament of Treitz, with an end-to-end jejuno-ileal 
anastomosis to restore continuity. Eight rats had a 75% proximal 
jejuno-ileal bypass. The bowel was divided distal to the ligament of 
Treitz, and the bowel distal to the division was closed, while the 
proximal bowel was anastomosed end-to-side to the ileum, 75% of the 
distance down the small bowel, thus excluding an equivalent amount of 
bowel to that resected in the first group (Fig 6.1). The last eight 
rats had transection of the bowel below the ligament of Treitz only, 
with reanastomosis. All anastomoses were constructed with a single 
layer of 6/0 black silk. Intramuscular Hypnorm (fentanyl and fluanisone) 
and intraperitoneal Valium (diazepam) were used for anaesthetic. 
Animals were allowed food (Pelleted Rat Diet - Labsure Animal Foods, 
Poole, Dorset) and water ad libitum. All animals were killed on the 
12th post operative day. At 9.30 hrs, all animals were given vincristine 
(Oncovin, Eli Lilly & Co. Ltd., Basingstoke, UK), by intraperitoneal 
injection in a dose of lmg/kg body weight, for measurement of cell 
kinetics. Animals were then killed at 20 minute intervals by ether 
anaesthesia and blood was taken immediately by direct cardiac puncture. 
~he blood was placed in heparinised tubes containing 0.2ml of aprotinin 
(Trasylol 20,000KIU/ml), centrifuged immediately, and the plasma was 
stored at -20°C to await radioimmunoassay for plasma gastrin and entero-
glucagon. A record was kept of the weight loss of the animals following 
surgery, and the amount of food consumed. 
- 103 -
RADIOIMMUNOASSAY: 
Assays for enteroglucagon (216) and gastrin (217) were performed as 
described in Chapter 3. 
CRYPT CELL PRODUCTION RATE (CCPR) (213,218): 
This was performed on the terminal ileum, as described in Chapter 3. 
STATISTICS: 
The students t-test for unpaired data was used for the group analysis 



























Fig 6.2: Plasma enteroglucagon and gastrin, and 
CCPR/h after intestinal resection, jejuno-
ileal bypass and jejunal transection. 
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RESULTS 
NUTRITIONAL INTAKE AND WEIGHT CHANGES: 
There was no significant difference in the amount of food consumed per 
day in the resected animals, jejuno-ileal bypass group and transected 
animals (21.s!sg, 23.5!6g, 19.5!3g respectively). ~he resected animals 
lost 18.7±6g and transected animals lost 14.2±9g·following operation. 
However, the animals with jejuno-ileal bypass lost 42.6!4g in body 
weight (P<0.01). 
CRYPT CELL PRODUCTION RATE (CCPR) (Fig 6.2): 
After 75% proximal jejuno-ileal bypass, the CCPR in the terminal ileum 
+ increased from 16.8-0.9 cells per crypt per hour in the transected 
control animals, to 37.8:2.2 cells per crypt per hour (P(0.001). The 
CCPR in jejuno-ileal bypass in the terminal ileum, was further increased 
+ to 49.2-4.9 cells per crypt per hour after 75% proximal resection (P(0.001). 
PLASMA ENTEROGLUCAGON (Fig 6.2): 
Plasma enteroglucagon increased from 99.1~9.6pmol/l in transected controls, 
to 340!62.4pmol/l in the jejuno-ileal bypass animals (P<0.001). While 
+ this level increased still further to 667-70.lpmol/l after 75% proximal 
resection (P(0.001). 
PLASMA GASTRIN (Fig 6.2): 
Although the increase in plasma gastrin from 38.1~4.3pmol/l in transected 
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+ to 81.9-13.3pmol/l in resected rats, was significant {P(0.005), there 
was no significant increase from control levels to those in jejuno-
ileal bypass (52.9!12.4pmol/l), nor was the difference between 
resection and bypass significantly different. 
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DISCUSSION 
The increased CCPR in the terminal ileum of the rats with jejuno-ileal 
bypass, compared with control transected animals in this study, is 
in keeping with previous reports of hyperplasia and increased absorp-
tive capacity in the residual small bowel in continuity after bypass 
(23,26,58,63,65). The finding of increased CCPR in the terminal 
ileum after resection compared with bypass, despite an equal amount 
of residual ileum in both procedures, is in agreement with the work 
of others (158) in which jejunectomy caused an initial greater ileal 
hyperplasia than an equivalent end-to-side jejunal bypass. This 
difference, however, was not observed from four weeks onward, when no 
morphologic or biochemical difference was found between excision and 
exclusion (26,158,241). The present study was of short duration (12 
days) so that the findings were in keeping with a more pronounced 
hyperplasia after resection compared with bypass, in the early post 
operative period. Of interest is the fact, that small bowel resection 
produces a higher azoxymethane induced colonic tumour yield compared 
with an equivalent small bowel bypass at 20 and 25 weeks, although the 
yields at 30 weeks were similiar (241). This may well be due to the 
earlier hyperplasia seen after resection, although the later adaptive 
effects of resection and bypass are similiar (241). 
The mechanisms of adaptation in the residual ileum in continuity, are 
probably similiar to those operative after intestinal resection. In 
contrast to the hyperplasia seen in the distal ileum in continuity with 
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the nutrient stream, the finding of marked hypoplasia in the defunction-
ed jejunum after jejuno-ileal bypass, with reduced absorptive capacity 
(23,26,58,63,65) is in favour of a role for the direct effect of luminal 
nutrition and possibly pancreatico-biliary secretions. Furthermore, this 
concept is supported by the fact, that these changes in the defunctioned 
jejunum, are completely reversed by restoration of normal intestinal 
continuity (58,63). However, evidence is available from work with 
defunctioned segments of bowel, which supports the concept that humoral 
agents are involved in the adaptive process after bypass procedures, and 
that these humoral agents probably mediate part of the trophic effect of 
luminal nutrition. Thus, increased cellular proliferation has been found 
in heterotropic autografts of ileal mucosa transplanted beneath the renal cap-
sule after partial enterectomy (242). Furthermore, the degree of mucosal 
hypoplasiafou~d in excluded intestinal segments, is decreased by partial 
resection of the bowel in continuity (57,88,89) as witnessed by morphologic 
and biochemical evidence of mucosal hyperplasia in these bypassed segments. 
However, the greater hyperplasia found in the bowel in continuity, suggests 
a combination of local (such as luminal nutrition) and humoral (systemic) 
factors. When animals with isolated segments of bowel, are deprived of 
food by mouth (91) or nourished exclusively by TPN (98,243), further hypo-
plastic changes occur in the isolated segment of bowel, compared with 
similiar animals with isolated loops of bowel, feeding normally. This 
suggests that humoral agents probably mediate part of the trophic effect 
of luminal nutrition, a concept supported by the fact that ileal infusion 
of glucose increases epithelial mass in the jejunum (244). In the present 
study, serum gastrin levels did not change significantly in relation to the 
changes in CCPR, and it seems very unlikely that this peptide can be 
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responsible, even in part, for the kinetic changes observed in these models. 
In contrast, however, serum concentrations of enteroglucagon changed in 
parallel to the CCPR in the terminal ileum. These changes in enteroglucagon 
after jejuno-ileal bypass, are in keeping with those reported after this 
procedure performed in man in the management of morbid obesity (70,149,245,246). 
As with proximalihtestinal resection, greater quantities of unabsorbed luminal 
nutrients are presented to the terminal ileum after jejuno-ileal bypass. 
This segment of bowel is particularly rich in EG cells (135) and these 
cells are stimulated to secrete enteroglucagon, mainly by luminal carbo-
hydrates and long chain fatty acids (137,138). It is well known that after 
an initial period of weight loss, patients who have had jejuno-ileal bypass 
for obesity, may regain a considerable amount of weight. This is probably 
due to the adaptation which takes place in the ileum in continuity. When 
patients with bypassed bowel have required repeat laparotomy, besides the 
gross enlargement of the residual adapted bowel in continuity, light and 
electron microscopic evaluation of the bypassed segments has surprisingly 
revealed no obvious evidence of widespread mucosal atrophy, as would be 
expected, although the segments had been bypassed from the alimentary stream 
for a number of years (247,248), and it has been suggested that non luminal 
or systemic factors are sufficient to maintain small intestinal mucosal 
integrity for long periods in the absence of intestinal chyme. It has 
been suggested that enteroglucagon, which may be as much as 16-fold elevated 
in the plasma postprandially after jejuno-ileal bypass, is the trophic 




In the models studied, significant adaptive hyperplasia occurs in the terminal 
ileum in continuity after jejuno-ileal bypass compared with intestinal tran-
section. However, the adaptation (at 12 days) after an equivalent intest-
inal resection, is significantly greater. As with intestinal resection, 
luminal nutrition is important, but it is likely that part of the effect 
of luminal nutrition is mediated via humoral agents. The results of this 
study indicate, that while gastrin does not fulfil the criteria for such a 
role, enteroglucagon must remain a favoured candidate. 
T H E E F F E C T 0 F 
P R O L I F E R A T I O N 
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C H A P T E R 7 
C O L E C T O M Y 
I N S M A L L 
0 N C E L L U L A R 
BOWEL, AND S E R U M 
G A S T R I N A N D E N T E R O G L U C A G O N L E V E L S 
INTRODUCTION 
After total colectomy or panproctocolectomy and ileostomy, the ileostomy 
effluent is initially watery and profuse, with electrolyte loss, and this 
may on occasion, be difficult to control. However, after a variable period 
of time, the effluent becomes more solid, less profuse, and very much easier 
to manage. This is due to ileal adaptation, and it has been shown by 
morphometric, cell proliferative and absorptive studies, that ileal 
adaptation after total/subtotal colectomy, takes place in rats (87), and 
man (86,249). Because of the unaltered length of small bowel after total 
colectomy it is unlikely that luminal nutrition or PBS could be implicated 
in bringing about these adaptive changes. The following study was under-
taken to investigate further the adaptive changes in the terminal ileum 
after total colectomy, and the possible trophic role of gastrin and entero-
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(a) (b) 
Fig 7.1: Ileal transection (a), and total colectomy and 
ilea-rectal anastomosis (b). 
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MATERIAL AND METHODS 
Eight male Wistar rats had a total colectomy, and continuity was restored 
by an end-to-end ilea-rectal anastomosis. A further eight rats acted as 
controls, and had an ileal 'transection just proximal to the ilea-caecal valve, 
with an end-to-end anastomosis to restore continuity (Fig 7.1). All rats 
weighed 200-250g at the time of surgery. Anaesthetic was by intramuscular 
Hypnorm (fentanyl and fluanisone) and intraperitoneal Valium (diazepam). 
All anastomoses were constructed with a single layer of 6/0 black silk. 
The animals were killed on the 12th post operative day. A record was kept 
of the daily food intake of the animals, and weight changes of the time of 
the study. On the 12th post operative day, all animals were given 
vincristine (Oncavin, Eli Lilly and Co. Ltd., Basingstoke, UK) at 9.30hrs, 
by intraperitoneal injection, in a dose of lmg/kg body weight, for cell 
kinetic measurements. Animals were then killed at 20 minutes intervals 
by ether anaesthesia, and blood was taken by direct cardiac puncture. The 
blood was placed in heparinised tubes containing 0.2ml of aprotinin (Tras-
ylol 20,000KIU/ml), centrifuged immediately, and the plasma stored at 
-20°C to await radioimmunoassay for plasma gastrin and enteroglucagon. 
RADIOIMMUNOASSAY: 
Assays for enteroglucagon (216) and gastrin (217) were performed as described 
in Chapter 3. 
CRYPT CELL PRODUCTION RATE (CCPR) (213,218): 
This was performed on tissue obtained from the terminal ileum of rats in 
both groups, as described in Chapter 3. 
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STATISTICAL METHODS: 
The students t-test for unpaired data was used for the group analysis, 
























Fig 7.2: Crypt cell production rate per hour (CCPR/h) in 
the terminal ileum, and plas~a enteroglucagon 




WEIGHT CHANGES AND FOOD INTAKE: 
Rats after total colectomy lost 38.4!6g in weight, while those with 
+ 
ileal transection only lost 10.4-7g (P<0.001). There was no significant 
difference in food intake per day in the colectomy and transected groups 
+ + (21.4-3g and 20.2-6g). 
CRYPT CELL PRODUCTION RATE (CCPR) (Fig 7.2): 
The CCPR in the terminal ileum after ileal transection was 1s!o.9 cells 
per crypt per hour. After total colectomy and ileo-rectal anastomosis, 
the CCPR in the terminal ileum increased to 31.2!1.19 cells per crypt per 
hour {P(0.001). 
PLASMA ENTEROGLUCAGON AND GASTRIN (Fig 7.2): 
The plasma enteroglucagon level after ileal transection was 108.8!3.2pmol/l, 
and this increased to 234.5!20.Spmol/l after total colectomy and ileo-rectal 
anastomosis {P(0.005). 
+ 
Similiarly, plasma gastrin increased from 23.11-3.8 




The CCPR findings in this study are in agreement with previous reports (86, 
87,249), that ileal adaptation takes place after total colectomy, and 
clinical impressions related to the reduction in ileostomy effluent and its 
change in character with time, support this. This being the case, in view 
of the unaltered length of small bowel in the two groups and the similiar 
food intake, it is unlikely that luminal nutrition can be held responsible 
for these changes. 
It is possible, therefore, that humoral factors may account for these changes. 
In this study, both enteroglucagon and gastrin were significantly raised 
after total colectomy compared with controls, and both these peptides may 
account for the ileal changes seen. However, previous studies (110,111) and 
results of the data in the preceeding chapters, suggests that gastrin plays 
little if any role in small bowel adaptation. 
Besides the effect of humoral agents, it is possible that motility changes 
may be involved. A decrease in intestinal motility and a delay in gastric 
emptying is known to occur after intestinal resections (40) and this is more 
pronounced after proximal than distal resections. In this respect, entero-
glucagon may be involved. This peptide, together with another distally 
located peptide, neurotension, has been implicated in the 'ileal brake' 
mechanismwherebyileal fat perfusion results in an inhibition of jejunal 
motility and delays caudal transit of jejunal contens (250). Enteroglucagon 
is known to potently inhibit pentagastrin-stimulated gastric acid secretion 
in the rat (134), and thus almost certainly acts as an enterogastrone. The 
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major concentration of enteroglucagon (EG) cells in the terminal ileum (135) is 
in keeping with a role for this peptide in the ileal adaptation seen in this 
study. Indeed, this may account for the diminished adaptation after ileal 
resections compared with proximal small bowel resection (251). However, 
after total colectomy, the'ileal brake
1 (250) is still intact. 
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CONCLUSION: 
This study confirms ileal adapation after total colectomy. In this respect, 
it is unlikely that luminal nutrition can be implicated in the pathogenesis 
of this adaptive response. The situation of the EG cells, and the role of 
this peptide as an enterogastrone and its involvement in the 'ileal brake' 
mechanism, makes enteroglucagon a favoured candidate for a humoral role in 
the ileal adaptation after total colectomy. 
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C H A P T E R 8 
T H E R E L A T I O N S H I P B E T W E E N C E L L PRO LI F-
E R A T I O N A N D E N D O G E N O U S G U T H O R M O N E S 
(GAST RI N A N D ENTER O GLUC AGO N) I N M O D E L S 
0 F I N T E S T I N A L A D A P T A T I O N 
INTRODUCTION 
In the previous chapters (2-7), models of intestinal adaptation have 
been used to determine the cell proliferation (CCPR) and plasma gastrin 
and enteroglucagon levels, twelve days after the procedure. The results 
of these experiments, make it possible to determine the relationship 
of these two peptides to cellular proliferation in the models studied. 
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MATERIAL AND METHODS 
The models used, have been described in detail in the previous chapters. 
These were:- 75% proximal small bowel Thiry-Vella fistula, with and 
without TPN (Chapter 3), 75% proximal small bowel resection, and jejunal 
transection, with normal feeding, hyperphagia or TPN (Chapter 4), 
pancreatico-biliary diversion into the colon, with and without 75% 
proximal small bowel resection (Chapter 5), 75% proximal small bowel 
jejuno-ileal bypass (Chapter 6), total colectomy or ileal transection 
(Chapter 7). One hundred and four male Wistar rats were used. The 
methods of anaesthesia and operative details have been described in 
the relevant chapters. All animals were killed on the twelfth post 
operative day. The crypt cell production rate (CCPR) in the terminal 
ileum (213,218) and plasma levels of gastrin (217) and enteroglucagon 
(216) were determined, as described in detail in Chapter 3. Taking the 
data from each of these 13 groups, the CCPR in the terminal ileum was 
correlated with plasma gastrin and enteroglucagon levels, using the 
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Fig 8.1: Correlation between crypt cell production rate 
per hour (CCPR/h) and plasma enteroglucagon in 
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RESULTS 
The relationship of CCPR and hormone levels is shown in Figures 8.1 and 
8.2. There was a strong correlation between terminal ileal CCPR and 
plasma enteroglucagon levels in the different models; Spearman rank 
correlation coefficient, r =0.649 (O.Ol(P<0.02). However, a poor relation-s 
ship between CCPR and gastrin was found r =0.439 (0.2.c:F<0.3). s 
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DISCUSSION 
The finding in this study, that there was a very poor correlation between 
plasma gastrin levels and the CCPR in the terminal ileum in the various 
models of adaptation suggests that gastrin probably has little, if any, 
trophic influence on the small bowel. Although the results of the 
two studies (104,106) employing the administration of pentagastrin, have 
suggested a trophic role for gastrin on small bowel, the vast majority of 
reports do not confirm this, and support the results of this study. 
Thus, pentagastrin administration for 15 days, had no influence on the 
distal duodenum and jejunum in rats, although there were increases in 
weight and height of the proximal duodenum (105). Furthermore, penta-
gastrin administration failed to abolish the hypoplasia in small bowel 
after resection with TPN; although there was an effect more proximally 
(107). Antrectomy has no effect on the growth of the small bowel, nor 
does it influence the adaptive response to partial enterectomy (108), 
and intragastric administration of gastrin has no trophic effect on the 
ileum (110). Thus, while gastrin almost certainly has a trophic influence 
on the stomach (with the exception of the antrum), duodenum, colon and 
pancreas (102,lll,112,113,114,117,118), the results of the present study 
and of other studies (105,107,108,110) suggests that gastrin has little 
trophic influence on small bowel. In support of this is the fact that 
although marked hyperplasia of gastric mucosa is found in cases of the 
Zollinger-Ellison syndrome (119), small bowel mucosal hyperplasia has not 
been recorded in this condition, or other conditions with hypergastrin-
aemia, such as pernicious anaemia or antral G-cell hyperplasia. 
In contrast to gastrin, there was a very strong correlation between 
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terminal ileal CCPR and plasma enteroglucagon in the models studied. 
Clearly, while these results do not demonstrate a cause-and-effect 
relationship, they suggest strongly that enteroglucagon may be involved 
in the adaptive process, either as the final factor in the pathway, 
having been released by luminal products such as food, or possibly by stim-
ulating the release of some other, as yet unrecognised, trophic agent. 
At the present time, there is a lack of sufficient pure enteroglucagon 
available for direct infusion studies. Nevertheless, an enteroglucagon-
enriched extract of rat intestine has recently been shown to produce a 
dose-dependent stimulation of DNA in guinea-pig jejunal mucosa over a 
concentration range similiar to that following intestinal resection (163), 
and this supports the results of the present study. Besides the trophic 
effects on small bowel noted in a patient with an enteroglucagon produc-
ing renal tumour (124,125), further support for the trophic effect of 
enteroglucagon on small bowel is derived from the findings of markedly 
raised enteroglucagon levels in clinical situations where intestinal 
adaptation is known to occur, such as untreated coeliac disease (143,144) 
tropical malabsorption (145) after small bowel resection (69) and jejuno-
ileal bypass (70,149) and when healthy infants commence enteral feeding 
(155). Indeed, the distal situation in the gut of the EG cells (135), 
the anatomy of these cells (71,129,136) and their ability to respond to 
changes in intraluminal fats and carbohydrates (137,138) all fit in with 




The results of this study suggest that gastrin has little trophic 
influence on small bowel mucosa. Conversely, enteroglucagon displays 
a strong correlation with CCPR in the terminal ileum in various models 
of intestinal adapatation and must be regarded as a possible factor in 
the regulation of small bowel growth. 
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C H A P T E R 9 
T H E E N T E R O G L U C A G O N R E L E A S E P A T T E R N 
A F T E R S M A L L B O W E L RESECTION, A N D I T S 
R E L A T I O N S H I P T 0 C E L L U L A R P R O L I F E R A T I O N 
INTRODUCTION 
In the predeeding studies, the plasma enteroglucagon levels in models of 
adaptation, have been shown to be closely correlated with cell turnover in 
the small bowel. Both enteroglucagon and CCPR, have been measured at 
12 days after the operation, and although a close relationship exists 
between these two parameters at this time, the following study was under-
taken to determine whether enteroglucagon rises rapidly enough to be 
involved in the early cellular response to intestinal resection and 
whether its influence persists in the maintenance of adaptive changes 
in the long term. 
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MATERIAL AND METHODS 
Male Wistar rats, weighing 250-350g at the time of surgery, were used 
for the study. The animals (n=96) were anaesthetised with intramuscular 
Hypnorm (fentany~ and fluanisone) and intraperitoneal diazepam (Valium). Half 
t~e animBls ~aa a 75% proximal small bowel resection, while the rest had 
an intestinal transection and re-anastomosis, just distal to the ligament 
of Treitz, as described in Chapter 4. All animals were allowed food ad 
libitum (pelleted rat diet). A record was kept of the food intake and 
weight changes over the experiment. Groups of rats (N=7-10) were killed 
at 1.5,3,6,12,24 and 48 days following surgery. On these days rats were 
given vincristine lmg/kg body weight, by intraperitoneal injection at 
9am. Thefirst animal was killed 30 minutes after this, and the following 
animals in the group were killed serially at 20 minute intervals there-
after, by ether anaesthesia. Blood (5-lOml) was taken by direct cardiac 
puncture, and placed into heparinised tubes containing 0.2ml of aprotinin 
(Trasylol, Bayer), centrifuged, and the separated plasma stored at -20°C 
to await assay. At the same time, 5cm segments of terminal ileum were 
taken for cell kinetic studies and prepared as described in Chapter 3. 
CRYPT CELL PRODUCTION RATE (213,218): 
This was performed as described in Chapter 3, and results expressed as 
cells per crypt per hour. 
PLASMA ENTEROGLUCAGON ASSAY (216): 
Radioimmunoassay of plasma for enteroglucagon, was performed as described 
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in Chapter 3, and results are given as pmol/1. 
STATISTICAL METHODS: 
The students' t-test for unpaired data was used for inter-group analysis, 




AVERAGE CUMULATIVE FOOD INTAKE PER ANIMAL (g, MEAN - SEM) 
Days Transection Resection 
food obser- food obser-
g vations g vations 
1. 5 5-:!:1 8 s:!:2 10 
.L 
23:!:2 3 23..:.2 8 7 
6 4g:!:7 7 9s:!:14 8 
12 10s:!:12 8 143:!:24 8 
24 2so:!:14 10 501:!:23 8 
48 925:!:72 7 1,059:!:45 7 
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Fig 9.1: Percentage weight change in animals over the 
48 day period. 
500 
400 
D = transection. LJ = resection. 
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+ Fig 9.2: Plasma enteroglucagon levels (mean - SEM) 
plotted against time after operation. 
* = P,0.005; : = P(0.001. numbers above each 
point denote n value. 
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Crypt cell production rate per hour (CCPR/h; 
mean: SEM) plotted against time after operation. 
o =resection;•= transection; : = P<0.001. 











Fig 9.4: Correlation between CCPR/h and plasma enteroglucagon. 
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RESULTS 
WEIGHT CHANGES AND FOOD INTAKE: 
These are shown in Fig 9.1 and Table 9.1 respectively. Both resected 
and transected animals lost weight in the initial post operative period, 
but then began gaining weight, and this weight gain was well established 
by 24 days. Throughout the experiment, resected animals lost more weight 
than transected controls, despite a higher food intake. 
PLASMA ENTEROGLUCAGON AND CCPR: 
Plasma enteroglucagon levels over the 48 days in both resected and 
transected animals, is shown in Fig 9.2, while the corresponding changes 
in CCPR are shown in Fig 9.3. Resected animals had plasma enteroglucagon 
levels three times greater than controls while CCPR was doubled as early 
as 1.5 days. Thereafter, there was a steady rise in both enteroglucagon 
and CCPR, and once the highest mean values were reached (CCPR between 
6-12 days and enteroglucagon at 24 days) the levels remained steady 
until 48 days. In transected animals, there was a small fall in entero-
glucagon and CCPR levels early on, followed by a slow rise to levels 
found at 1.5 days. Taking all groups as a whole, there was a strong 
correlation (r=0.95;P(0.001) between plasma enteroglucagon concentrations 
and CCPR throughout the experiment (Fig 9.4). 
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DISCUSSION 
Previous studies (85,86,108,158) have indicated, that intense hyperplasia 
of ileal mucosa is well established within 48 hours of proximal small 
bowel resection. This 'anticipatory' adaptation occurs at a time when 
food intake is not fully established, and mechanisms other than luminal 
nutrition must be operative. This is supported by the finding in this 
study, of a significantly greater CCPR in resected compared with transect-
ed rats at 1.5 days. The food intake at this stage was minimal once 
again supporting the concept that a systemic factor, other than luminal 
nutrition, might be operative. Enteroglucagon levels at this early 
stage (1.5 days) were significantly greater in resected, compared with 
transected animals. Although luminal contents, in particular, carbo-
hydrates and triglycerides, are known to be the major stimulants of 
enteroglucagon release (137,138), it has been shown in rats nourished 
exclusively by TPN, that resected animals have significantly greater 
levels of plasma enteroglucagon and greater cell production rates in 
the terminal ileum, compared with transected animals (97), although 
these levels were well below those in rats taking food by mouth. 
Thus, other, albeit less potent stimuli to enteroglucagon release after 
intestinal resection, must exist, and may be particularly relevant to the 
enteroglucagon and CCPR levels after resection at 1.5 days, in this study. 
Throughout the study, a close parallelism was seen between plasma entero-
glucagon and CCPR levels, both in the resected and transected animals, 
with a very close correlation between these two parameters. This does 
not mean a cause-and-effect relationship, but provides further strong 
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circumstantial evidence for enteroglucagon as an 'enterotrophin'. Miazza
 
et al (84), using the model of pancreatico-biliary diversion (PBD), have 
shown intestinal mucosal hyperplasia and high plasma levels of enterogluc
-
agon, eight days after the procedure, but at three months after PBD, 
although the degree of mucosal hyperplasia was maintained, plasma entero-
glucagon had returned to normal. This suggested that enteroglucagon may 
play a part in initiating the adaptive process. but does not contribute 
to its ~aintenance. This is in contrast to the findings in the present 
study, in which high levels of enteroglucagon were found in the plasma 
for the duration of the experiment up to 48 days, and is in agreement 
with the finding of raised plasma enteroglucagon in man after small 
bowel resection, both in the basal and postprandial states (69). 
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CONCLUSION 
The findings in this study, not only confirm a close relationship 
between enteroglucagon levels in the plasma and mucosal enterocyte 
production rate at different times after small bowel resection, but 
also show that levels of this peptide do rise quickly enough to be 
involved in the initial rapid 'anticipatory' adaptation after resection, 
and are persistent enough to be involved in the maintenance of this 
adaptation. The finding of a very early rise in CCPR, before oral 
feeding is fully established, argues for a humoral factor in the 
mechanism of adaptation, and enteroglucagon appears to be a strong 
candidate for such a role. 
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C H A P T E R 1 0 
T H E E F F E C T 0 F E X O G E N O U S H O R M O N E S 0 N 
P L A S M A E ~ T E R O G L U C A G O N A N D C E L L 
P R O L I F E R A T I O N A F T E R I N T E S T I N A L 
R E S E C T I O N 
INTRODUCTION 
Enteroglucagon has emerged as a favoured candidate for a role as 'en-
terotrophin' to small bowel mucosa. Although luminal nutrients 
are important stimulants for the release of enteroglucagon (137,138), 
with alterations in the amount of orally ingested food effecting both 
plasma enteroglucagon levels and cell turnover after intestinal surgery 
(97), other factors may well contribute to the release of this peptide. 
and hence effect cell proliferation under certain conditions. Thus, 
the marked rise in CCPR and plasma enteroglucagon which occurs very 
early after intestinal resection (85,86,108,158,252) is not entirely 
related to luminal nutrition, as food intake at this stage is minimal. 
Furthermore, rats nourished solely on TPN, exhibit a modest but 
significant rise in enteroglucagon and CCPR after intestinal resection, 
compared with transected controls (97). 
In the following study, somatostatin which suppresses (142), and bombesin 
which stimulates (140,141) the release of enteroglucagon, were admin-
istered to rats after intestinal resection and transection, and the 
effect of these peptides on plasma enteroglucagon and cell proliferation 
was observed. 
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MATERIAL AND METHODS 
Forty-eight male Wistar rats, weighing 200-250g at the time of surgery, 
were used in the study. Half the rats had a 75% proximal small bowel 
resection, while the remainder had a jejunal transection only, as 
described in detail in Chapter 4. Diazepam and Hypnorm were used as 
anaesthetic. Animals were allowed water and food (pelleted rat diet), 
ad libitum. The 48 animals were divided into 3 groups, each group 
comprising 8 animals with resection, and 8 with transection. Group 1, 













100/1g in lOS,Ml rat plasma subcutaneously twice a day for the last seven 
days of the experiment. Group 2 animals were given bombesin for a similiar 
period, and this was administered via the Alzet osmotic minipump, model 
2001 (Scientific Marketing Associates, London), which was implanted 
subcutaneously at the back of the animals neck. Each pump, which delivers 
a constant flow at a rate of 1;11/hour for one week, and has a capacity 
of 16~1, was filled with a solution of bombesin, 9~g in 100J11 normal 
saline. Group 3 animals were given a minipump containing saline only, 
over the last 7 days of the experiment, and this group acted as control. 
On the 12th post operative day, animals were given Vincristine, lmg/kg 
body weight by intraperitoneal injection, at 9.00hrs. The first rat was 
killed at 9.30am, and the following animals serially at 20 minute intervals 
thereafter. Five cm segments of terminal ileum were taken for cell kinetic 
studies, as described in Chapter 3. At the same time, blood was taken 
by direct cardiac puncture, and placed in heparinised tubes containing 
0.2ml of aprotinin (Trasylol, Bayer), centrifuged, and the separated 
plasma stored at -20°C to await assay. 
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A record was kept of the food intake and weight changes over the course 
of the experiment. 
CRYPT CELL PRODUCTION RATE (213,218): 
This was performed as described,in Chapter 3, and results expressed as 
cells per crypt per hour. 
PLASMA ENTEROGLUCAGON ASSAY (216): 
This was performed as described in Chapter 3 and results expressed in 
pmol/1. 
STATISTICAL METHODS: 
The students t-test for unpaired data was used for group analysis, 
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Fig 10.1: Plasma enteroglucagon and CCPR/h after 75% 
resection and jejunal transection, in 
animals administered somatostatin and con-
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Fig 10.2: Plasma enteroglucagon and CCPR/h after 75% 
proximal small bowel resection and jejunal 
transection, in animals having bombesin 
administration, and controls with saline 
administration. B bombesin. 
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RESULTS 
FOOD INTAKE AND BODY WEIGHT: 
There was no significant difference in food intake per day between the 
three groups (21.4!3g, 23.1!2g and 24!3g respectively), nor were the 
weight changes significantly different, with all animals approaching 
their pre-operative weights at the conclusion of the experiment. 
CCPR AND PLASMA ENTEROGLUCAGON (Figs 10.1,10.2): 
In the control animals (Group 3), there was an increase in CCPR/hr in the 
terminal ileum from 16.s!o.9 in transected, to49.2!4.9 in resected 
animals (P<0.001) (Fig 10.1). Similiarly, plasma enteroglucagon increased 
from 99.1!9.6pmol/l in transected, to 557!70.lpmol/l in resected rats 
(P<0.001). 
After administration of somatostatin (Group 1), rats with resection had 
a fall in CCPR to 15.4! compared with resected control rats (Group 3) 
(P(0.001) (Fig 10.1). There was also R fall jn olasma enteroglucagon jn 
resected Group 1 rats compared with resected controls (Group 3) (P<0.001). 
Although there was a fall in plasma enteroglucagon in transected rats 
+ 
administered somatostatin (26.3-8.9pmol/l) compared with control animals 
(P(0.001), there was no significant change in CCPR in the two groups. 
After administration of bombesin (Group 2), transected rats showed a rise 
in CCPR to 24.5!1.9 (P(0.005) with a concommitant rise in enteroglucagon 
+ to 218-34pmol/l (P(0.005) compared to transected controls, (Fig. 10.2). 
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However, the resected bombesin tr~~tec rats showed no change in CCPR 
and plasma enteroglucagon compared with the resected control group. 
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DISCUSSION 
The data in this study show that small intestinal cell proliferation 
can be influenced by gastro-intestinal hormones. There are, of course, 
a number of possible explanations for these results. It may be, 
that bombesin and somatostatin have a direct influence on cell 
proliferation. Bombesin administration has been shown to induce 
antral gastrin cell hyperplasia (254) and th~s increase both antral 
and serum gastrin concentrations in rats (255). Its direct effect on 
small bowel mucosa is unknown. Similiarly, somatostatin, which has a 
wide range of inhibitory actions on the gut, may have a direct anti-
trophic influence on cell proliferation. Secondly, these peptides 
might exert their influence on cell proliferation, by inducing alter-
ations in luminal nutrition, intestinal secretions or other hormeo-
static mechanisms. In this study, there was no difference between 
the groups in terms of food intake and weight changes, which makes 
this second possibility unlikely. This is supported by the results 
of other workers (256) who found that somatostatin infusion for 4 
days in rats, had no effect on either plasma concentrations of 
glucose, insulin, glucagon, growth hormone and cyclic AMP, or on 
body weight gain, food consumption or water intake. 
Finally, it is possible that both bombesin and somatostatin may have 
induced the effects seen, by influencing other trophic hormones. The 
influence of these peptides on gastrin is well established. Bombesin, 
a tetradecapeptide first isolated from amphibian skin, has been shown to 
have a powerful stimulatory effect on gastric acid secretion (257) and 
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the release of gastrin from the gastric antrum (255,258) and is con-
sequently also called gastrin-releasing peptide (GRP). Somatostatin, 
on the other hand, suppresses gastric acid secretion (259,260) and the 
release of gastrin (260,261,262,263). Gastrin was not measured in this 
study, but as it is not thought to have any significant trophic influence 
on small bowel mucosa (105,107,108,109,110), it is unlikely that the 
changes in cell proliferation after administration of bombesin and 
somatostatin noted in this study, could have been mediated via this 
peptide. Somatostatin administration in this study, resulted in a fall 
in plasma enteroglucagon concentrations, in both transected and resect-
ed rats, while bombesin administration produced a rise in enterogluc-
agon only in transected animals, the resected group showing no change 
compared to controls. Changes in CCPR showed a similiar trend to changes 
in enteroglucagon, excepted that somatostatin administered transected 
animals did not have a fall in CCPR to follow the fall in enteroglucagon, 
and it may well be, that there is a threshold below which it is not 
possible to inhibit cellular proliferation by somatostatin administration. 
Similiarly, the inability of bombesin to increase both enteroglucagon and 
CCPR still further after intestinal resection, could represent a limit-
ing factor over and above which it is not possible to increase cell 
proliferation and peptide secretion, from the already very high levels 
observed after 75% proximal small bowel resection. In view of the close 
relatioship between the changes in plasma enteroglucagon and CCPR 
observed in this study, it is possible that the effect of somatostatin 
and bombesin on cellular proliferation are mediated via enteroglucagon, 
although the data do not allow a distinction to be made between this, 
or other possible modes of action, such as a direct effect of these 
two peptides on cell turnover. 
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CONCLUSION 
The results of this study indicate that hormones can influence cellular 
proliferation in small bowel mucosa. It is possible that these changes 
may be mediated via changes in enteroglucagon, although further invest-
igation is required to elucidate the exact mechanism. The data, however, 
provide further circumstantial evidence, for the involvement of entero-
glucagon in the mechanism of small bowel adaptation. 
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INTRODUCTION 
The major stimuli for the release of enteroglucagon after a meal are 
carbohydrates and long chain fatty acids (137,138). The enteroglucagon 
cells (EG cells) are found distally in the gut where the highest con-
centration is in the ileal mucosa, with lesser, but still significant 
concentrations found in the colon (135). The finding of raised con-
centrations of enteroglucagon in coeliac disease (143,144), tropical 
malabsorption (145), infective diarrhoea (146), after total pancreat-
ectomy (147) and in patients with chronic pancreatitis and steattorrhoea 
(148), after small bowel resection (69) and jejuno-ileal bypass (70,149), 
all situations where there is rapid intestinal transit, has prompted 
the hypothesis that these raised levels of the peptide are brought about 
by abnormal and excessive exposure of the distal intestine, and thus the 
major concentrations of EG cell~ to chyme which is rich in unabsorbed 
nutrients. These nutrients have not been absorbed higher in the gastro-
intestinal tract, either because of rapid intestinal transit, or due to 
disease of this part of the gut, or because of surgical removal or by-
pass of the upper small bowel. To test this hypothesis, plasma entero-
glucagon changes were measured in patients after gastric surgery, who 
were given an oral glucose load. These patients could be expected to 
have rapid upper intestinal transit due to the changes in gastric empty-
ing consequent on the surgery. Changes in haematocrit and blood glucose, 
as well as subjective and objective signs of dumping were sought and 
these changes were compared with control subjects. 
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MATERIAL AND METHODS 
Twenty-one patients were used in this study, and they were divided into 
3 groups. Group A was comprised of 7 patients with total or near total 
gastrectomy with oesophago - or gastroenterostomy. Groups B consisted of 
7 patients after upper oartialgastrectomy, but with an intact, unstenosed 
pylorus. All patients in Groups A and B had an associated truncal 
vagotomy, and were studied between one and 18 months after surgery. 
Seven patients who had not had previous surgery, and were awaiting 
routine operations, such as hernia repair, were used as controls, and 
comprised Group C. 
All patients were studied after an overnight fast. An indwelling 'butter-
fly' cannula was placed into a large antecubital vein, and serial blood 
samples of 10ml were taken for enteroglucagon levels, haematocrit and 
blood sugar estimations. The blood for hormone assay, was placed into 
heparin tubes containing 200~1 of aprotinin (Trasylol 20,000KIU/ml), 
was centrifuged immediately, and the plasma stored at -20°C to await 
assay. 
Each patient was asked to drink 200ml 50% glucose solution over 2 
minutes. Blood samples were taken 15 minutes before and at the time of 
drinking the solution, and then at 15,30,45,60 and 90 minutes after 
ingestion. Throughout the test the presence of symptoms and signs of 
the dumping syndrome, suchas abdominal fullness and pain, sweating, 
diarrhoea, faintness and tachycardia, were sought. 
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PLASMA ENTEROGLUCAGON ASSAY (216): 
This was performed as described in Chapter 3. 
PACKED CELL VOLUME: 
The PCV was determined using a Coulter Model S Counter. Changes in 
haematocrit were regarded as a good index of plasma volume change 
(264). 
BLOOD GLUCOSE: 
This was calculated by the glucose oxidase method (265). 
STATISTICAL METHODS: 
The students t-test for unpaired data was used for group analysis, 
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Fig 11.1: Plasma enteroglucagon levels after oral 
glucose. •=total/near total gastrectomy; 
~=upper partial gastrectomy; o = controls. 
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TABLE 11.1 
CHANGES IN HAEMATOCRIT AFTER GLUCOSE INGESTION (mean and s.e.m. values). 
Haematocrit 
change(%) 
(basal to 45 min) 
Rate of rise or fall 
of haematocrit (%/min) 


















The enteroglucagon release pattern during the test in the three groups 
is shown in Fig 11.1. While no difference existed between Groups A and 
Bin the level of enteroglucagon after glucose ingestion, these levels 
were significantly greater than in controls (P<0.001). Furthermore, 
although the mean rate of rise of enteroglucagon, measured from basal 
levels to 45 minutes after ingestion of glucose was similiar in Group A 
+ -1 -1 + -1 -1 
and B (13.3-2.6pmol min 1 and 12.2-2.lpmol min 1 respectively), 
this was significantly more rapid than in control subjects (1.2!0.2pmol 
-1 -1 
min 1 ) (P<0.001). 
HAEMATOCRIT CHANGES: 
The change in haematocrit from basal levels to 45 min after glucose 
ingestion is shown in Table 11.1. While both gastrectomy groups showed 
a rise in haematocrit, signifying a fall in plasma volume, there was a 
drop in haematocrit in the control group, and the differences between 
the gastrectomy patients and controls, were highly significant. 
BLOOD GLUCOSE: 
The changes in blood glucose during the test is shown in Fig 11.2. 
There was a significantly greater rise of glucose in gastrectomy groups 
compared to the controls. Similiarly, while the mean rate of rise of 
glucose, measured from basal levels to 60min, was not significantly 
different in +
 -1 -1 + 




































Fig 11. 3: 
15 30 45 60 120 
Time lminutesl 
Blood glucose levels after oral glucose 
load. •=Total/near total gastrectomy; 
A= upper partial gastrectomy; o = controls. 
15 30 45 60 120 
Time lminutesl 
Changes in pulse rate after glucose 
ingestion. •=total/near total 
gastrectomy; A= upper partial gastrectomy; 
o = controls. 
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min -ll-l respectively), these rates were significantly more rapid than 
+ -1 -1 
in control subjects (0.06-0.02mmol min 1 ) (P(0.025 and P(0.02 respect-
ively). 
OCCURENCE OF DUMPING: 
Six patients in each gastrectomy group experienced subjective symptoms 
of dumping during the test, while none of the control group were affect-
ed. Objectively, the changes in pulse rate in the three groups 
(Fig 11.3) were in keeping with the occurrence of dumping symptoms. 
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DISCUSSION 
The dumping syndrome is thought to be due to rapid gastric emptying of 
hyperosmolar nutrients, which will attract water from the circulation, 
the intestinal epithelium actingas a semi-permeable membrane (266). This 
results in a fall in plasma volume (267), the magnitude of which is 
directly related to the rate of gastric emptying (268). 
In the present study, a standard dumping provocation test was employed 
(269) to test the 3 groups. Group A patients, who had had a total 
gastrectomy, would be expected to exhibit dumping symptoms after 
the provocation test. Group B patients, had an intact pylorus, but 
upper partial gastrectomy has an unavoidable truncal vagotomy associated 
with it. Patients after vagotomy have impairment of receptive relaxation 
and accommodation to distension by the gastric smooth muscle with raised 
postprandial intragastric pressure, and this results in more rapid 
emptying of liquids from the vagotomised stomach (270). Group B patients 
thus also exhibited dumping after the provocation test, probably due to 
the rapid emptying of the glucose solution, while dumping did not occur 
in controls. The presence of the dumping syndrome in Groups A and B, 
was determined by subjective evidence of symptoms complained of by the 
patient, such as abdominal pain and fullness, nausea, faintness, sweating 
and diarrhoea, in addition to a significantly more rapid pulse rate in 
the two groups during the test, compared with controls. Furthermore, 
the findings of a rise in haematocrit, and a higher and more rapid 
increase in blood glucose in gastrectomised patients compared with 
controls, is in keeping with dumping in Groups A and B, but not in Group 
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C. Changes in haematocrit are regarded as a good index of plasma 
volume change (264), with a rise in haematocrit indicating a fall in 
plasma volume. As mentioned before, a fall in plasma volume is thought 
to be a major factor in the pathophysiology of the dumping syndrome (267). 
It is also well established that blood glucose levels after oral hyper-
tonic glucose, are higher in patients with dumping symptoms than in 
asymptomatic postoperative duodenal ulcer patients (271). Thus, it 
seems that in the present study, the above mentioned findings in Groups 
A and Bare due to rapid gastric emptying and increased transit down the 
small bowel. Plasma enteroglucagon levels were markedly raised after 
oral glucose ingestion, in Groups A and B, with a much greater rate of 
rise, compared with Group C, and it seems likely, that like the changes 
in haematocrit and blood glucose, the plasma enteroglucagon changes in 
gastrectomised patients, are alsodueto rapid gastric emptying and intest-
inal transit. In this situation, the distally placed EG cells in the 
ileum (135), would be subjected to a greater volume of nutrients which 
have not been absorbed higher up because of the rapid transit, thus 
releasing increased concentrations of enteroglucagon. 
The findings in the above study, confirm the hypothesis, that in many 
situations where intestinal adaptation occurs, the raised levels of 
enteroglucagon found post-prandially, are due to the rapid transit of 
nutrients down the gut, thus bombarding the EG cells with unabsorbed 
nutrients. After proximal small intestinal resection or jejuno-ileal 
bypass, the upper small bowel is missing, and nutrients, pass from the 
stomach and duodenum, directly into the enteroglucagon rich ileum. The 
EG cells in the distal small bowel and colon (135) are thus ideally 
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located to respond in these situations, and the above findings confirm 
this, and provides further support for the role of enteroglucagon in 
the adaptive process. 
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CONCLUSION 
The results of this study support the hypothesis that hypersecretion of 
enteroglucagon in situations of rapid intestinal transit, is due to the 
EG cells in the distal ileum and colon being stimulated by chyme rich in 
unabsorbed nutrients, which is presented rapidly to this part of the gut. 
Such a situation exists after proximal small bowel resection, and many 
of the situations where intestinal adaptation takes place, and argues in 
favour of a role for enteroglucagon in this process. 
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C H A P T E R 1 2 
S U M M A R Y A N D F I N A L C O N C L U S I O N 
The findings in the various studies outlined in the preceeding chapters, 
confirm that adaptive changes occur in the distal small bowel in contin-
uity after either proximal small bowel resection or bypass, as indicat-
ed by the increase in crypt cell production rates in these models. 
Furthermore, there is confirmation that luminal nutrients (Chapter 4) 
and pancreatico-biliary secretions (PBS) (Chapter 5) are important as 
mechanisms in this adaptation. However, luminal nutrition and PBS cannot 
explain all the findings in these studies. Thus, the terminal ileal 
adaptive changes after total colectomy compared with ileal transection 
alone (Chapter 7) cannot be explained on the basis of luminal nutrition, 
as the length of small bowel is unaltered, and food intake in these 
animals was not different from controls. Similiarly, the very early 
adaptive changes after intestinal resection seen at 36 hours after 
resection, are well established and marked, despite a very much reduced 
food intake at this stage (Chapter 9). Furthermore, after intestinal 
resection, rats maintained on TPN have significantly greater cell 
proliferation than transected control animals on TPN (Chapter 4), once 
again indicating that factors other than luminal nutrition must be oper-
ative. 
The findings of increased adaptive changes (or lack of hypoplasia) seen 
in isolated Thiry-Vella fistulae in orally fed rats, compared with simil-
iar animals maintained on TPN (Chapter 3) argues that luminal nutrition 
releases a systemic factor, which then passes via the circulation, to 
bring about these changes in the isolated fistula. That humoral factors 
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or hormones can influence cell proliferation, is clearly shown in Chapter 
10. 
The data in these studies, provide strong circumstantial evidence that 
enteroglucagon should be regarded as a likely candidate for the role of 
humoral 'enterotrophin' in the mechanism of the adaptive process. In 
all the studies, enteroglucagon and CCPR changes showed a very close 
correlation (Chapter 8), while the lack of such a relationship between 
gastrin and cell proliferation, excludes this peptide as having any 
trophic influence on small bowel mucosa. Furthermore, the findings after 
intestinal resection over a prolonged period (Chapter 9), shows that 
enteroglucagon is released in sufficient quantities in the early 
stages of the adaptive process, and that the release of this peptide in 
high concentrations overa prolonged period would allow for the maintenance 
of cell proliferation, thus providing further support for enteroglucagon 
as a growth factor to small bowel. Enteroglucagon is released by carbo-
hydrates and long chain triglycerides, and the findings in Chapter 11 
indicated that the mechanism of hypersecretion of this peptide, is 
stimulation of the distally placed EG cells by luminal content which is 
rich in unabsorbed nutrients passing rapidly down the gut. This mechanism 
almost certainly operates after proximal small bowel resection and jejuno-
ileal bypass, and the various other malabsorption states, such as coeliac 
disease, in which intestinal adaptation occurs. Furthermore, the amount 
of food ingested is important to the degree of enteroglucagon release, 
and the strength of the adaptive response (Chapter 4) once again indic-
ating the interrelationship between these two factors and their influence 
on adaptation. 
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The process of intestinal adaptation is complex and almost certainly 
multifactorial, and it is likely that the various trophic mechanisms 
act in a co-ordinated fashion. Thus ingested nutrition and other 
luminal secretions, such as bile and pancreatic juice, are clearly 
important. They probably act in two ways, firstly by a direct trophic 
effect on the residual mucosa, support for this concept being that they 
are gradient-based, and secondly by indirect influences, the most import-
ant of these being the release of trophic hormone. The trophic 
hormones may in turn act locally, in a paracrine fashion, or have a more 
systemic (endocrine) effect. Of the hormones thus far investigated, 
enteroglucagon has emerged as the most likely candidate for a trophic 
role on small bowel mucosa. The results of the work presented, provide 
further strong support for this concept. Enteroglucagon has, however, 
not been purified in sufficient quantities for direct infusional studies 
to be undertaken, although recently, an enteroglucagon-enriched extract 
of rat intestine has been shown to produce a dose-dependent stimulation 
of DNA synthesis in guinea-pig jejunal mucosa over a concentration 
range similiar to that found following intestinal resection (164). Clear-
ly, a pure preparation is ~eeded for direct infusional studies to be 
carried out, and this promises to be an important and exciting avenue 
of investigation in the field of intestinal adaptation. 
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